CN110036021A - Make the Compounds and methods for of molecular targeted specific cells position - Google Patents
Make the Compounds and methods for of molecular targeted specific cells position Download PDFInfo
- Publication number
- CN110036021A CN110036021A CN201780065902.5A CN201780065902A CN110036021A CN 110036021 A CN110036021 A CN 110036021A CN 201780065902 A CN201780065902 A CN 201780065902A CN 110036021 A CN110036021 A CN 110036021A
- Authority
- CN
- China
- Prior art keywords
- cell
- vire2
- conjugate
- peptide
- asp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 37
- 150000001875 compounds Chemical class 0.000 title claims description 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 25
- 230000008569 process Effects 0.000 claims abstract description 20
- 229940079593 drug Drugs 0.000 claims abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 12
- 238000012984 biological imaging Methods 0.000 claims abstract description 10
- 229940000406 drug candidate Drugs 0.000 claims abstract description 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 7
- 210000004027 cell Anatomy 0.000 claims description 123
- 150000001413 amino acids Chemical class 0.000 claims description 30
- 210000004899 c-terminal region Anatomy 0.000 claims description 24
- 102000005853 Clathrin Human genes 0.000 claims description 8
- 108010019874 Clathrin Proteins 0.000 claims description 8
- 229930193282 clathrin Natural products 0.000 claims description 8
- 230000003834 intracellular effect Effects 0.000 claims description 4
- 241000195493 Cryptophyta Species 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 claims description 2
- 102000020313 Cell-Penetrating Peptides Human genes 0.000 claims description 2
- 108010051109 Cell-Penetrating Peptides Proteins 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- 210000004962 mammalian cell Anatomy 0.000 claims description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 3
- 230000012202 endocytosis Effects 0.000 description 49
- 241000589158 Agrobacterium Species 0.000 description 35
- 241000196324 Embryophyta Species 0.000 description 32
- 244000061176 Nicotiana tabacum Species 0.000 description 30
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 30
- 235000001014 amino acid Nutrition 0.000 description 23
- 230000035772 mutation Effects 0.000 description 23
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 22
- 239000005090 green fluorescent protein Substances 0.000 description 22
- 210000000170 cell membrane Anatomy 0.000 description 20
- 241000894006 Bacteria Species 0.000 description 18
- 230000001580 bacterial effect Effects 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- 241000219194 Arabidopsis Species 0.000 description 15
- 108090000623 proteins and genes Proteins 0.000 description 15
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 14
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 14
- 206010028980 Neoplasm Diseases 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 14
- 235000018102 proteins Nutrition 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 14
- 230000014509 gene expression Effects 0.000 description 13
- 101100162824 Arabidopsis thaliana AP2M gene Proteins 0.000 description 12
- 238000012545 processing Methods 0.000 description 12
- 210000002615 epidermis Anatomy 0.000 description 11
- 239000013612 plasmid Substances 0.000 description 11
- 230000032258 transport Effects 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 9
- 210000000805 cytoplasm Anatomy 0.000 description 8
- 210000001163 endosome Anatomy 0.000 description 8
- 108010021843 fluorescent protein 583 Proteins 0.000 description 8
- 230000003993 interaction Effects 0.000 description 8
- 230000010474 transient expression Effects 0.000 description 8
- 241000880493 Leptailurus serval Species 0.000 description 7
- 239000013598 vector Substances 0.000 description 7
- 101100423825 Arabidopsis thaliana SYP61 gene Proteins 0.000 description 6
- 238000009825 accumulation Methods 0.000 description 6
- 230000002776 aggregation Effects 0.000 description 6
- 238000004220 aggregation Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000006395 clathrin-mediated endocytosis Effects 0.000 description 5
- 239000000975 dye Substances 0.000 description 5
- 238000004043 dyeing Methods 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 230000008595 infiltration Effects 0.000 description 5
- 238000001764 infiltration Methods 0.000 description 5
- 101000953488 Homo sapiens Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 Proteins 0.000 description 4
- 102100037736 Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 Human genes 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 4
- 108010077850 Nuclear Localization Signals Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 108010038633 aspartylglutamate Proteins 0.000 description 4
- 108010047857 aspartylglycine Proteins 0.000 description 4
- 230000027455 binding Effects 0.000 description 4
- 239000012636 effector Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000001339 epidermal cell Anatomy 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 108020001507 fusion proteins Proteins 0.000 description 4
- 102000037865 fusion proteins Human genes 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 108010034529 leucyl-lysine Proteins 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
- XVZCXCTYGHPNEM-UHFFFAOYSA-N Leu-Leu-Pro Natural products CC(C)CC(N)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(O)=O XVZCXCTYGHPNEM-UHFFFAOYSA-N 0.000 description 3
- BMVFXOQHDQZAQU-DCAQKATOSA-N Leu-Pro-Asp Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)O)N BMVFXOQHDQZAQU-DCAQKATOSA-N 0.000 description 3
- PPGBXYKMUMHFBF-KATARQTJSA-N Leu-Ser-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PPGBXYKMUMHFBF-KATARQTJSA-N 0.000 description 3
- XQLBWXHVZVBNJM-FXQIFTODSA-N Pro-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 XQLBWXHVZVBNJM-FXQIFTODSA-N 0.000 description 3
- KLOZTPOXVVRVAQ-DZKIICNBSA-N Tyr-Val-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 KLOZTPOXVVRVAQ-DZKIICNBSA-N 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 108010068380 arginylarginine Proteins 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 238000003119 immunoblot Methods 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 239000012139 lysis buffer Substances 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 210000004940 nucleus Anatomy 0.000 description 3
- 108010051242 phenylalanylserine Proteins 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000002864 sequence alignment Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- SUQWGICKJIJKNO-IHRRRGAJSA-N (2s)-2-[[2-[[(2s)-6-amino-2-[[(2s)-2,6-diaminohexanoyl]amino]hexanoyl]amino]acetyl]amino]pentanedioic acid Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O SUQWGICKJIJKNO-IHRRRGAJSA-N 0.000 description 2
- VTJXFTPMFYAJJU-UHFFFAOYSA-N 2-[(3,4-dihydroxyphenyl)methylidene]propanedinitrile Chemical compound OC1=CC=C(C=C(C#N)C#N)C=C1O VTJXFTPMFYAJJU-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- LGFCAXJBAZESCF-ACZMJKKPSA-N Ala-Gln-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O LGFCAXJBAZESCF-ACZMJKKPSA-N 0.000 description 2
- MFMDKJIPHSWSBM-GUBZILKMSA-N Ala-Lys-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O MFMDKJIPHSWSBM-GUBZILKMSA-N 0.000 description 2
- SUHLZMHFRALVSY-YUMQZZPRSA-N Ala-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)NCC(O)=O SUHLZMHFRALVSY-YUMQZZPRSA-N 0.000 description 2
- DYXOFPBJBAHWFY-JBDRJPRFSA-N Ala-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)N DYXOFPBJBAHWFY-JBDRJPRFSA-N 0.000 description 2
- LYILPUNCKACNGF-NAKRPEOUSA-N Ala-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)N LYILPUNCKACNGF-NAKRPEOUSA-N 0.000 description 2
- JTKLCCFLSLCCST-SZMVWBNQSA-N Arg-Arg-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)N)C(O)=O)=CNC2=C1 JTKLCCFLSLCCST-SZMVWBNQSA-N 0.000 description 2
- MAISCYVJLBBRNU-DCAQKATOSA-N Arg-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N MAISCYVJLBBRNU-DCAQKATOSA-N 0.000 description 2
- OTUQSEPIIVBYEM-IHRRRGAJSA-N Arg-Asn-Tyr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O OTUQSEPIIVBYEM-IHRRRGAJSA-N 0.000 description 2
- XVLLUZMFSAYKJV-GUBZILKMSA-N Arg-Asp-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O XVLLUZMFSAYKJV-GUBZILKMSA-N 0.000 description 2
- JSHVMZANPXCDTL-GMOBBJLQSA-N Arg-Asp-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JSHVMZANPXCDTL-GMOBBJLQSA-N 0.000 description 2
- LLZXKVAAEWBUPB-KKUMJFAQSA-N Arg-Gln-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LLZXKVAAEWBUPB-KKUMJFAQSA-N 0.000 description 2
- OHYQKYUTLIPFOX-ZPFDUUQYSA-N Arg-Glu-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O OHYQKYUTLIPFOX-ZPFDUUQYSA-N 0.000 description 2
- QKSAZKCRVQYYGS-UWVGGRQHSA-N Arg-Gly-His Chemical compound N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O QKSAZKCRVQYYGS-UWVGGRQHSA-N 0.000 description 2
- OTZMRMHZCMZOJZ-SRVKXCTJSA-N Arg-Leu-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O OTZMRMHZCMZOJZ-SRVKXCTJSA-N 0.000 description 2
- VEAIMHJZTIDCIH-KKUMJFAQSA-N Arg-Phe-Gln Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O VEAIMHJZTIDCIH-KKUMJFAQSA-N 0.000 description 2
- OVQJAKFLFTZDNC-GUBZILKMSA-N Arg-Pro-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O OVQJAKFLFTZDNC-GUBZILKMSA-N 0.000 description 2
- UZSQXCMNUPKLCC-FJXKBIBVSA-N Arg-Thr-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O UZSQXCMNUPKLCC-FJXKBIBVSA-N 0.000 description 2
- UVTGNSWSRSCPLP-UHFFFAOYSA-N Arg-Tyr Natural products NC(CCNC(=N)N)C(=O)NC(Cc1ccc(O)cc1)C(=O)O UVTGNSWSRSCPLP-UHFFFAOYSA-N 0.000 description 2
- CGWVCWFQGXOUSJ-ULQDDVLXSA-N Arg-Tyr-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O CGWVCWFQGXOUSJ-ULQDDVLXSA-N 0.000 description 2
- LLQIAIUAKGNOSE-NHCYSSNCSA-N Arg-Val-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N LLQIAIUAKGNOSE-NHCYSSNCSA-N 0.000 description 2
- WVCJSDCHTUTONA-FXQIFTODSA-N Asn-Asp-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O WVCJSDCHTUTONA-FXQIFTODSA-N 0.000 description 2
- ZWASIOHRQWRWAS-UGYAYLCHSA-N Asn-Asp-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ZWASIOHRQWRWAS-UGYAYLCHSA-N 0.000 description 2
- WONGRTVAMHFGBE-WDSKDSINSA-N Asn-Gly-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)N WONGRTVAMHFGBE-WDSKDSINSA-N 0.000 description 2
- OPEPUCYIGFEGSW-WDSKDSINSA-N Asn-Gly-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O OPEPUCYIGFEGSW-WDSKDSINSA-N 0.000 description 2
- RAKKBBHMTJSXOY-XVYDVKMFSA-N Asn-His-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(O)=O RAKKBBHMTJSXOY-XVYDVKMFSA-N 0.000 description 2
- KEUNWIXNKVWCFL-FXQIFTODSA-N Asn-Met-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(O)=O KEUNWIXNKVWCFL-FXQIFTODSA-N 0.000 description 2
- HCZQKHSRYHCPSD-IUKAMOBKSA-N Asn-Thr-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HCZQKHSRYHCPSD-IUKAMOBKSA-N 0.000 description 2
- LRCIOEVFVGXZKB-BZSNNMDCSA-N Asn-Tyr-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LRCIOEVFVGXZKB-BZSNNMDCSA-N 0.000 description 2
- NECWUSYTYSIFNC-DLOVCJGASA-N Asp-Ala-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 NECWUSYTYSIFNC-DLOVCJGASA-N 0.000 description 2
- QHAJMRDEWNAIBQ-FXQIFTODSA-N Asp-Arg-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O QHAJMRDEWNAIBQ-FXQIFTODSA-N 0.000 description 2
- VPSHHQXIWLGVDD-ZLUOBGJFSA-N Asp-Asp-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O VPSHHQXIWLGVDD-ZLUOBGJFSA-N 0.000 description 2
- JUWZKMBALYLZCK-WHFBIAKZSA-N Asp-Gly-Asn Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O JUWZKMBALYLZCK-WHFBIAKZSA-N 0.000 description 2
- AWPWHMVCSISSQK-QWRGUYRKSA-N Asp-Tyr-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O AWPWHMVCSISSQK-QWRGUYRKSA-N 0.000 description 2
- GYNUXDMCDILYIQ-QRTARXTBSA-N Asp-Val-Trp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC(=O)O)N GYNUXDMCDILYIQ-QRTARXTBSA-N 0.000 description 2
- 108091006146 Channels Proteins 0.000 description 2
- LDIKUWLAMDFHPU-FXQIFTODSA-N Cys-Cys-Arg Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O LDIKUWLAMDFHPU-FXQIFTODSA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- RZSLYUUFFVHFRQ-FXQIFTODSA-N Gln-Ala-Glu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O RZSLYUUFFVHFRQ-FXQIFTODSA-N 0.000 description 2
- KVYVOGYEMPEXBT-GUBZILKMSA-N Gln-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O KVYVOGYEMPEXBT-GUBZILKMSA-N 0.000 description 2
- JEFZIKRIDLHOIF-BYPYZUCNSA-N Gln-Gly Chemical compound NC(=O)CC[C@H](N)C(=O)NCC(O)=O JEFZIKRIDLHOIF-BYPYZUCNSA-N 0.000 description 2
- GLEGHWQNGPMKHO-DCAQKATOSA-N Gln-His-Glu Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N GLEGHWQNGPMKHO-DCAQKATOSA-N 0.000 description 2
- QKCZZAZNMMVICF-DCAQKATOSA-N Gln-Leu-Glu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O QKCZZAZNMMVICF-DCAQKATOSA-N 0.000 description 2
- ROHVCXBMIAAASL-HJGDQZAQSA-N Gln-Met-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)N)N)O ROHVCXBMIAAASL-HJGDQZAQSA-N 0.000 description 2
- DOQUICBEISTQHE-CIUDSAMLSA-N Gln-Pro-Asp Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O DOQUICBEISTQHE-CIUDSAMLSA-N 0.000 description 2
- KUBFPYIMAGXGBT-ACZMJKKPSA-N Gln-Ser-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O KUBFPYIMAGXGBT-ACZMJKKPSA-N 0.000 description 2
- KVQOVQVGVKDZNW-GUBZILKMSA-N Gln-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N)N KVQOVQVGVKDZNW-GUBZILKMSA-N 0.000 description 2
- VOUSELYGTNGEPB-NUMRIWBASA-N Gln-Thr-Asp Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O VOUSELYGTNGEPB-NUMRIWBASA-N 0.000 description 2
- NLKVNZUFDPWPNL-YUMQZZPRSA-N Glu-Arg-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O NLKVNZUFDPWPNL-YUMQZZPRSA-N 0.000 description 2
- PCBBLFVHTYNQGG-LAEOZQHASA-N Glu-Asn-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N PCBBLFVHTYNQGG-LAEOZQHASA-N 0.000 description 2
- QPRZKNOOOBWXSU-CIUDSAMLSA-N Glu-Asp-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N QPRZKNOOOBWXSU-CIUDSAMLSA-N 0.000 description 2
- WDTAKCUOIKHCTB-NKIYYHGXSA-N Glu-His-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCC(=O)O)N)O WDTAKCUOIKHCTB-NKIYYHGXSA-N 0.000 description 2
- WTMZXOPHTIVFCP-QEWYBTABSA-N Glu-Ile-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 WTMZXOPHTIVFCP-QEWYBTABSA-N 0.000 description 2
- FBEJIDRSQCGFJI-GUBZILKMSA-N Glu-Leu-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O FBEJIDRSQCGFJI-GUBZILKMSA-N 0.000 description 2
- OFIHURVSQXAZIR-SZMVWBNQSA-N Glu-Lys-Trp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O OFIHURVSQXAZIR-SZMVWBNQSA-N 0.000 description 2
- TZXOPHFCAATANZ-QEJZJMRPSA-N Glu-Ser-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)N TZXOPHFCAATANZ-QEJZJMRPSA-N 0.000 description 2
- QCMVGXDELYMZET-GLLZPBPUSA-N Glu-Thr-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QCMVGXDELYMZET-GLLZPBPUSA-N 0.000 description 2
- HJTSRYLPAYGEEC-SIUGBPQLSA-N Glu-Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCC(=O)O)N HJTSRYLPAYGEEC-SIUGBPQLSA-N 0.000 description 2
- SOYWRINXUSUWEQ-DLOVCJGASA-N Glu-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCC(O)=O SOYWRINXUSUWEQ-DLOVCJGASA-N 0.000 description 2
- UGVQELHRNUDMAA-BYPYZUCNSA-N Gly-Ala-Gly Chemical compound [NH3+]CC(=O)N[C@@H](C)C(=O)NCC([O-])=O UGVQELHRNUDMAA-BYPYZUCNSA-N 0.000 description 2
- XQHSBNVACKQWAV-WHFBIAKZSA-N Gly-Asp-Asn Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O XQHSBNVACKQWAV-WHFBIAKZSA-N 0.000 description 2
- SWQALSGKVLYKDT-UHFFFAOYSA-N Gly-Ile-Ala Natural products NCC(=O)NC(C(C)CC)C(=O)NC(C)C(O)=O SWQALSGKVLYKDT-UHFFFAOYSA-N 0.000 description 2
- ZOTGXWMKUFSKEU-QXEWZRGKSA-N Gly-Ile-Met Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(O)=O ZOTGXWMKUFSKEU-QXEWZRGKSA-N 0.000 description 2
- LHYJCVCQPWRMKZ-WEDXCCLWSA-N Gly-Leu-Thr Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LHYJCVCQPWRMKZ-WEDXCCLWSA-N 0.000 description 2
- RUDRIZRGOLQSMX-IUCAKERBSA-N Gly-Met-Met Chemical compound [H]NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(O)=O RUDRIZRGOLQSMX-IUCAKERBSA-N 0.000 description 2
- FGPLUIQCSKGLTI-WDSKDSINSA-N Gly-Ser-Glu Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O FGPLUIQCSKGLTI-WDSKDSINSA-N 0.000 description 2
- WNGHUXFWEWTKAO-YUMQZZPRSA-N Gly-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN WNGHUXFWEWTKAO-YUMQZZPRSA-N 0.000 description 2
- ABPRMMYHROQBLY-NKWVEPMBSA-N Gly-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)CN)C(=O)O ABPRMMYHROQBLY-NKWVEPMBSA-N 0.000 description 2
- KZTLOHBDLMIFSH-XVYDVKMFSA-N His-Ala-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O KZTLOHBDLMIFSH-XVYDVKMFSA-N 0.000 description 2
- UOAVQQRILDGZEN-SRVKXCTJSA-N His-Asp-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O UOAVQQRILDGZEN-SRVKXCTJSA-N 0.000 description 2
- ZZLWLWSUIBSMNP-CIUDSAMLSA-N His-Asp-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O ZZLWLWSUIBSMNP-CIUDSAMLSA-N 0.000 description 2
- VBOFRJNDIOPNDO-YUMQZZPRSA-N His-Gly-Asn Chemical compound C1=C(NC=N1)C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)O)N VBOFRJNDIOPNDO-YUMQZZPRSA-N 0.000 description 2
- VDHOMPFVSABJKU-ULQDDVLXSA-N His-Phe-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC2=CN=CN2)N VDHOMPFVSABJKU-ULQDDVLXSA-N 0.000 description 2
- XGBVLRJLHUVCNK-DCAQKATOSA-N His-Val-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O XGBVLRJLHUVCNK-DCAQKATOSA-N 0.000 description 2
- LKACSKJPTFSBHR-MNXVOIDGSA-N Ile-Gln-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)O)N LKACSKJPTFSBHR-MNXVOIDGSA-N 0.000 description 2
- BEWFWZRGBDVXRP-PEFMBERDSA-N Ile-Glu-Asn Chemical compound [H]N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O BEWFWZRGBDVXRP-PEFMBERDSA-N 0.000 description 2
- YSGBJIQXTIVBHZ-AJNGGQMLSA-N Ile-Lys-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O YSGBJIQXTIVBHZ-AJNGGQMLSA-N 0.000 description 2
- PXKACEXYLPBMAD-JBDRJPRFSA-N Ile-Ser-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PXKACEXYLPBMAD-JBDRJPRFSA-N 0.000 description 2
- YJRSIJZUIUANHO-NAKRPEOUSA-N Ile-Val-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)O)N YJRSIJZUIUANHO-NAKRPEOUSA-N 0.000 description 2
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 2
- IBMVEYRWAWIOTN-UHFFFAOYSA-N L-Leucyl-L-Arginyl-L-Proline Natural products CC(C)CC(N)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(O)=O IBMVEYRWAWIOTN-UHFFFAOYSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- LJHGALIOHLRRQN-DCAQKATOSA-N Leu-Ala-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N LJHGALIOHLRRQN-DCAQKATOSA-N 0.000 description 2
- XIRYQRLFHWWWTC-QEJZJMRPSA-N Leu-Ala-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 XIRYQRLFHWWWTC-QEJZJMRPSA-N 0.000 description 2
- OIARJGNVARWKFP-YUMQZZPRSA-N Leu-Asn-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O OIARJGNVARWKFP-YUMQZZPRSA-N 0.000 description 2
- PJYSOYLLTJKZHC-GUBZILKMSA-N Leu-Asp-Gln Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCC(N)=O PJYSOYLLTJKZHC-GUBZILKMSA-N 0.000 description 2
- VQPPIMUZCZCOIL-GUBZILKMSA-N Leu-Gln-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O VQPPIMUZCZCOIL-GUBZILKMSA-N 0.000 description 2
- DLCXCECTCPKKCD-GUBZILKMSA-N Leu-Gln-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O DLCXCECTCPKKCD-GUBZILKMSA-N 0.000 description 2
- PTRKPHUGYULXPU-KKUMJFAQSA-N Leu-Phe-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O PTRKPHUGYULXPU-KKUMJFAQSA-N 0.000 description 2
- UCBPDSYUVAAHCD-UWVGGRQHSA-N Leu-Pro-Gly Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UCBPDSYUVAAHCD-UWVGGRQHSA-N 0.000 description 2
- SBANPBVRHYIMRR-UHFFFAOYSA-N Leu-Ser-Pro Natural products CC(C)CC(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O SBANPBVRHYIMRR-UHFFFAOYSA-N 0.000 description 2
- LSLUTXRANSUGFY-XIRDDKMYSA-N Leu-Trp-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(O)=O)C(O)=O LSLUTXRANSUGFY-XIRDDKMYSA-N 0.000 description 2
- VUBIPAHVHMZHCM-KKUMJFAQSA-N Leu-Tyr-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CC1=CC=C(O)C=C1 VUBIPAHVHMZHCM-KKUMJFAQSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- PNPYKQFJGRFYJE-GUBZILKMSA-N Lys-Ala-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O PNPYKQFJGRFYJE-GUBZILKMSA-N 0.000 description 2
- CLBGMWIYPYAZPR-AVGNSLFASA-N Lys-Arg-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O CLBGMWIYPYAZPR-AVGNSLFASA-N 0.000 description 2
- GGAPIOORBXHMNY-ULQDDVLXSA-N Lys-Arg-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)N)O GGAPIOORBXHMNY-ULQDDVLXSA-N 0.000 description 2
- DEFGUIIUYAUEDU-ZPFDUUQYSA-N Lys-Asn-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O DEFGUIIUYAUEDU-ZPFDUUQYSA-N 0.000 description 2
- GKFNXYMAMKJSKD-NHCYSSNCSA-N Lys-Asp-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O GKFNXYMAMKJSKD-NHCYSSNCSA-N 0.000 description 2
- PGBPWPTUOSCNLE-JYJNAYRXSA-N Lys-Gln-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)N PGBPWPTUOSCNLE-JYJNAYRXSA-N 0.000 description 2
- PRSBSVAVOQOAMI-BJDJZHNGSA-N Lys-Ile-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCCCN PRSBSVAVOQOAMI-BJDJZHNGSA-N 0.000 description 2
- OVAOHZIOUBEQCJ-IHRRRGAJSA-N Lys-Leu-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O OVAOHZIOUBEQCJ-IHRRRGAJSA-N 0.000 description 2
- MUXNCRWTWBMNHX-SRVKXCTJSA-N Lys-Leu-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O MUXNCRWTWBMNHX-SRVKXCTJSA-N 0.000 description 2
- XOQMURBBIXRRCR-SRVKXCTJSA-N Lys-Lys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN XOQMURBBIXRRCR-SRVKXCTJSA-N 0.000 description 2
- TWPCWKVOZDUYAA-KKUMJFAQSA-N Lys-Phe-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O TWPCWKVOZDUYAA-KKUMJFAQSA-N 0.000 description 2
- ZJSZPXISKMDJKQ-JYJNAYRXSA-N Lys-Phe-Glu Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(O)=O)CC1=CC=CC=C1 ZJSZPXISKMDJKQ-JYJNAYRXSA-N 0.000 description 2
- ZUGVARDEGWMMLK-SRVKXCTJSA-N Lys-Ser-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN ZUGVARDEGWMMLK-SRVKXCTJSA-N 0.000 description 2
- MIMXMVDLMDMOJD-BZSNNMDCSA-N Lys-Tyr-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O MIMXMVDLMDMOJD-BZSNNMDCSA-N 0.000 description 2
- SBSIKVMCCJUCBZ-GUBZILKMSA-N Met-Asn-Arg Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCNC(N)=N SBSIKVMCCJUCBZ-GUBZILKMSA-N 0.000 description 2
- DNDVVILEHVMWIS-LPEHRKFASA-N Met-Asp-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N DNDVVILEHVMWIS-LPEHRKFASA-N 0.000 description 2
- FYRUJIJAUPHUNB-IUCAKERBSA-N Met-Gly-Arg Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCNC(N)=N FYRUJIJAUPHUNB-IUCAKERBSA-N 0.000 description 2
- GVIVXNFKJQFTCE-YUMQZZPRSA-N Met-Gly-Gln Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O GVIVXNFKJQFTCE-YUMQZZPRSA-N 0.000 description 2
- SLQDSYZHHOKQSR-QXEWZRGKSA-N Met-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCSC SLQDSYZHHOKQSR-QXEWZRGKSA-N 0.000 description 2
- RRIHXWPHQSXHAQ-XUXIUFHCSA-N Met-Ile-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(O)=O RRIHXWPHQSXHAQ-XUXIUFHCSA-N 0.000 description 2
- LUYURUYVNYGKGM-RCWTZXSCSA-N Met-Pro-Thr Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O LUYURUYVNYGKGM-RCWTZXSCSA-N 0.000 description 2
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 2
- QCHNRQQVLJYDSI-DLOVCJGASA-N Phe-Asn-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 QCHNRQQVLJYDSI-DLOVCJGASA-N 0.000 description 2
- XNQMZHLAYFWSGJ-HTUGSXCWSA-N Phe-Thr-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O XNQMZHLAYFWSGJ-HTUGSXCWSA-N 0.000 description 2
- FCCBQBZXIAZNIG-LSJOCFKGSA-N Pro-Ala-His Chemical compound C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O FCCBQBZXIAZNIG-LSJOCFKGSA-N 0.000 description 2
- FUVBEZJCRMHWEM-FXQIFTODSA-N Pro-Asn-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O FUVBEZJCRMHWEM-FXQIFTODSA-N 0.000 description 2
- NXEYSLRNNPWCRN-SRVKXCTJSA-N Pro-Glu-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NXEYSLRNNPWCRN-SRVKXCTJSA-N 0.000 description 2
- SBVPYBFMIGDIDX-SRVKXCTJSA-N Pro-Pro-Pro Chemical compound OC(=O)[C@@H]1CCCN1C(=O)[C@H]1N(C(=O)[C@H]2NCCC2)CCC1 SBVPYBFMIGDIDX-SRVKXCTJSA-N 0.000 description 2
- KIDXAAQVMNLJFQ-KZVJFYERSA-N Pro-Thr-Ala Chemical compound C[C@@H](O)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](C)C(O)=O KIDXAAQVMNLJFQ-KZVJFYERSA-N 0.000 description 2
- NBDHWLZEMKSVHH-UVBJJODRSA-N Pro-Trp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@@H]3CCCN3 NBDHWLZEMKSVHH-UVBJJODRSA-N 0.000 description 2
- NRCJWSGXMAPYQX-LPEHRKFASA-N Ser-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)N)C(=O)O NRCJWSGXMAPYQX-LPEHRKFASA-N 0.000 description 2
- QPFJSHSJFIYDJZ-GHCJXIJMSA-N Ser-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CO QPFJSHSJFIYDJZ-GHCJXIJMSA-N 0.000 description 2
- DSGYZICNAMEJOC-AVGNSLFASA-N Ser-Glu-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O DSGYZICNAMEJOC-AVGNSLFASA-N 0.000 description 2
- NUEHQDHDLDXCRU-GUBZILKMSA-N Ser-Pro-Arg Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O NUEHQDHDLDXCRU-GUBZILKMSA-N 0.000 description 2
- BSXKBOUZDAZXHE-CIUDSAMLSA-N Ser-Pro-Glu Chemical compound [H]N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O BSXKBOUZDAZXHE-CIUDSAMLSA-N 0.000 description 2
- DINQYZRMXGWWTG-GUBZILKMSA-N Ser-Pro-Pro Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DINQYZRMXGWWTG-GUBZILKMSA-N 0.000 description 2
- WLJPJRGQRNCIQS-ZLUOBGJFSA-N Ser-Ser-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O WLJPJRGQRNCIQS-ZLUOBGJFSA-N 0.000 description 2
- JURQXQBJKUHGJS-UHFFFAOYSA-N Ser-Ser-Ser-Ser Chemical compound OCC(N)C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(CO)C(O)=O JURQXQBJKUHGJS-UHFFFAOYSA-N 0.000 description 2
- UKKROEYWYIHWBD-ZKWXMUAHSA-N Ser-Val-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O UKKROEYWYIHWBD-ZKWXMUAHSA-N 0.000 description 2
- WFUAUEQXPVNAEF-ZJDVBMNYSA-N Thr-Arg-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CCCN=C(N)N WFUAUEQXPVNAEF-ZJDVBMNYSA-N 0.000 description 2
- JXKMXEBNZCKSDY-JIOCBJNQSA-N Thr-Asp-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N)O JXKMXEBNZCKSDY-JIOCBJNQSA-N 0.000 description 2
- HJOSVGCWOTYJFG-WDCWCFNPSA-N Thr-Glu-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N)O HJOSVGCWOTYJFG-WDCWCFNPSA-N 0.000 description 2
- VYEHBMMAJFVTOI-JHEQGTHGSA-N Thr-Gly-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O VYEHBMMAJFVTOI-JHEQGTHGSA-N 0.000 description 2
- IMULJHHGAUZZFE-MBLNEYKQSA-N Thr-Gly-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O IMULJHHGAUZZFE-MBLNEYKQSA-N 0.000 description 2
- KBBRNEDOYWMIJP-KYNKHSRBSA-N Thr-Gly-Thr Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)O)N)O KBBRNEDOYWMIJP-KYNKHSRBSA-N 0.000 description 2
- LKJCABTUFGTPPY-HJGDQZAQSA-N Thr-Pro-Gln Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O LKJCABTUFGTPPY-HJGDQZAQSA-N 0.000 description 2
- BKIOKSLLAAZYTC-KKHAAJSZSA-N Thr-Val-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O BKIOKSLLAAZYTC-KKHAAJSZSA-N 0.000 description 2
- JONPRIHUYSPIMA-UWJYBYFXSA-N Tyr-Ala-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JONPRIHUYSPIMA-UWJYBYFXSA-N 0.000 description 2
- MICSYKFECRFCTJ-IHRRRGAJSA-N Tyr-Arg-Asp Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)O MICSYKFECRFCTJ-IHRRRGAJSA-N 0.000 description 2
- XHALUUQSNXSPLP-UFYCRDLUSA-N Tyr-Arg-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 XHALUUQSNXSPLP-UFYCRDLUSA-N 0.000 description 2
- PMDWYLVWHRTJIW-STQMWFEESA-N Tyr-Gly-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 PMDWYLVWHRTJIW-STQMWFEESA-N 0.000 description 2
- AKLNEFNQWLHIGY-QWRGUYRKSA-N Tyr-Gly-Asp Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)N)O AKLNEFNQWLHIGY-QWRGUYRKSA-N 0.000 description 2
- FMXFHNSFABRVFZ-BZSNNMDCSA-N Tyr-Lys-Leu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O FMXFHNSFABRVFZ-BZSNNMDCSA-N 0.000 description 2
- GQVZBMROTPEPIF-SRVKXCTJSA-N Tyr-Ser-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O GQVZBMROTPEPIF-SRVKXCTJSA-N 0.000 description 2
- NWEGIYMHTZXVBP-JSGCOSHPSA-N Tyr-Val-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O NWEGIYMHTZXVBP-JSGCOSHPSA-N 0.000 description 2
- CVUDMNSZAIZFAE-UHFFFAOYSA-N Val-Arg-Pro Natural products NC(N)=NCCCC(NC(=O)C(N)C(C)C)C(=O)N1CCCC1C(O)=O CVUDMNSZAIZFAE-UHFFFAOYSA-N 0.000 description 2
- HHSILIQTHXABKM-YDHLFZDLSA-N Val-Asp-Phe Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(O)=O HHSILIQTHXABKM-YDHLFZDLSA-N 0.000 description 2
- PWRITNSESKQTPW-NRPADANISA-N Val-Gln-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N PWRITNSESKQTPW-NRPADANISA-N 0.000 description 2
- URIRWLJVWHYLET-ONGXEEELSA-N Val-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)C(C)C URIRWLJVWHYLET-ONGXEEELSA-N 0.000 description 2
- SDSCOOZQQGUQFC-GVXVVHGQSA-N Val-His-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N SDSCOOZQQGUQFC-GVXVVHGQSA-N 0.000 description 2
- RYQUMYBMOJYYDK-NHCYSSNCSA-N Val-Pro-Glu Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)O)N RYQUMYBMOJYYDK-NHCYSSNCSA-N 0.000 description 2
- GBIUHAYJGWVNLN-UHFFFAOYSA-N Val-Ser-Pro Natural products CC(C)C(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O GBIUHAYJGWVNLN-UHFFFAOYSA-N 0.000 description 2
- 102000035181 adaptor proteins Human genes 0.000 description 2
- 108091005764 adaptor proteins Proteins 0.000 description 2
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 2
- 108010044940 alanylglutamine Proteins 0.000 description 2
- 108010087924 alanylproline Proteins 0.000 description 2
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 108010008355 arginyl-glutamine Proteins 0.000 description 2
- 108010069926 arginyl-glycyl-serine Proteins 0.000 description 2
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 2
- 108010093581 aspartyl-proline Proteins 0.000 description 2
- 108010092854 aspartyllysine Proteins 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000013000 chemical inhibitor Substances 0.000 description 2
- 102000014907 clathrin heavy chain Human genes 0.000 description 2
- 108060001643 clathrin heavy chain Proteins 0.000 description 2
- 102000014908 clathrin light chain Human genes 0.000 description 2
- 108060001644 clathrin light chain Proteins 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 2
- 108010078144 glutaminyl-glycine Proteins 0.000 description 2
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 2
- 108010079413 glycyl-prolyl-glutamic acid Proteins 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 108010083708 leucyl-aspartyl-valine Proteins 0.000 description 2
- 108010073472 leucyl-prolyl-proline Proteins 0.000 description 2
- 108010009298 lysylglutamic acid Proteins 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- 108010012581 phenylalanylglutamate Proteins 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- 108010025488 pinealon Proteins 0.000 description 2
- 108010004914 prolylarginine Proteins 0.000 description 2
- 108010090894 prolylleucine Proteins 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 108010026333 seryl-proline Proteins 0.000 description 2
- 108010071207 serylmethionine Proteins 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 230000017105 transposition Effects 0.000 description 2
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
- 108010051110 tyrosyl-lysine Proteins 0.000 description 2
- 108010009962 valyltyrosine Proteins 0.000 description 2
- 101150076562 virB gene Proteins 0.000 description 2
- 230000001018 virulence Effects 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- 239000011534 wash buffer Substances 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- 108010027345 wheylin-1 peptide Proteins 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- SHYYAQLDNVHPFT-DLOVCJGASA-N Ala-Asn-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SHYYAQLDNVHPFT-DLOVCJGASA-N 0.000 description 1
- LZRNYBIJOSKKRJ-XVYDVKMFSA-N Ala-Asp-His Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N LZRNYBIJOSKKRJ-XVYDVKMFSA-N 0.000 description 1
- SMCGQGDVTPFXKB-XPUUQOCRSA-N Ala-Gly-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N SMCGQGDVTPFXKB-XPUUQOCRSA-N 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 241000269350 Anura Species 0.000 description 1
- 108700031686 Arabidopsis SYP61 Proteins 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- BMNVSPMWMICFRV-DCAQKATOSA-N Arg-His-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(O)=O)C(O)=O)CC1=CN=CN1 BMNVSPMWMICFRV-DCAQKATOSA-N 0.000 description 1
- FNXCAFKDGBROCU-STECZYCISA-N Arg-Ile-Tyr Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 FNXCAFKDGBROCU-STECZYCISA-N 0.000 description 1
- NMRHDSAOIURTNT-RWMBFGLXSA-N Arg-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N NMRHDSAOIURTNT-RWMBFGLXSA-N 0.000 description 1
- XSPKAHFVDKRGRL-DCAQKATOSA-N Arg-Pro-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O XSPKAHFVDKRGRL-DCAQKATOSA-N 0.000 description 1
- VRTWYUYCJGNFES-CIUDSAMLSA-N Arg-Ser-Gln Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O VRTWYUYCJGNFES-CIUDSAMLSA-N 0.000 description 1
- YNSUUAOAFCVINY-OSUNSFLBSA-N Arg-Thr-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YNSUUAOAFCVINY-OSUNSFLBSA-N 0.000 description 1
- QCTOLCVIGRLMQS-HRCADAONSA-N Arg-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O QCTOLCVIGRLMQS-HRCADAONSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- MEFGKQUUYZOLHM-GMOBBJLQSA-N Asn-Arg-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MEFGKQUUYZOLHM-GMOBBJLQSA-N 0.000 description 1
- WQLJRNRLHWJIRW-KKUMJFAQSA-N Asn-His-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC(=O)N)N)O WQLJRNRLHWJIRW-KKUMJFAQSA-N 0.000 description 1
- RTFWCVDISAMGEQ-SRVKXCTJSA-N Asn-Phe-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N RTFWCVDISAMGEQ-SRVKXCTJSA-N 0.000 description 1
- WUQXMTITJLFXAU-JIOCBJNQSA-N Asn-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)N)N)O WUQXMTITJLFXAU-JIOCBJNQSA-N 0.000 description 1
- KRXIWXCXOARFNT-ZLUOBGJFSA-N Asp-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O KRXIWXCXOARFNT-ZLUOBGJFSA-N 0.000 description 1
- FANQWNCPNFEPGZ-WHFBIAKZSA-N Asp-Asp-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O FANQWNCPNFEPGZ-WHFBIAKZSA-N 0.000 description 1
- WBDWQKRLTVCDSY-WHFBIAKZSA-N Asp-Gly-Asp Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O WBDWQKRLTVCDSY-WHFBIAKZSA-N 0.000 description 1
- LNENWJXDHCFVOF-DCAQKATOSA-N Asp-His-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC(=O)O)N LNENWJXDHCFVOF-DCAQKATOSA-N 0.000 description 1
- RXBGWGRSWXOBGK-KKUMJFAQSA-N Asp-Lys-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O RXBGWGRSWXOBGK-KKUMJFAQSA-N 0.000 description 1
- GPPIDDWYKJPRES-YDHLFZDLSA-N Asp-Phe-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O GPPIDDWYKJPRES-YDHLFZDLSA-N 0.000 description 1
- ZBYLEBZCVKLPCY-FXQIFTODSA-N Asp-Ser-Arg Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O ZBYLEBZCVKLPCY-FXQIFTODSA-N 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- CHRCKSPMGYDLIA-SRVKXCTJSA-N Cys-Phe-Ser Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O CHRCKSPMGYDLIA-SRVKXCTJSA-N 0.000 description 1
- NAPULYCVEVVFRB-HEIBUPTGSA-N Cys-Thr-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)CS NAPULYCVEVVFRB-HEIBUPTGSA-N 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Divinylene sulfide Natural products C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- HWEINOMSWQSJDC-SRVKXCTJSA-N Gln-Leu-Arg Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O HWEINOMSWQSJDC-SRVKXCTJSA-N 0.000 description 1
- HLRLXVPRJJITSK-IFFSRLJSSA-N Gln-Thr-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O HLRLXVPRJJITSK-IFFSRLJSSA-N 0.000 description 1
- DSPQRJXOIXHOHK-WDSKDSINSA-N Glu-Asp-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O DSPQRJXOIXHOHK-WDSKDSINSA-N 0.000 description 1
- MTAOBYXRYJZRGQ-WDSKDSINSA-N Glu-Gly-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MTAOBYXRYJZRGQ-WDSKDSINSA-N 0.000 description 1
- OGNJZUXUTPQVBR-BQBZGAKWSA-N Glu-Gly-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O OGNJZUXUTPQVBR-BQBZGAKWSA-N 0.000 description 1
- IVGJYOOGJLFKQE-AVGNSLFASA-N Glu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N IVGJYOOGJLFKQE-AVGNSLFASA-N 0.000 description 1
- QJVZSVUYZFYLFQ-CIUDSAMLSA-N Glu-Pro-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O QJVZSVUYZFYLFQ-CIUDSAMLSA-N 0.000 description 1
- WIKMTDVSCUJIPJ-CIUDSAMLSA-N Glu-Ser-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N WIKMTDVSCUJIPJ-CIUDSAMLSA-N 0.000 description 1
- RXJFSLQVMGYQEL-IHRRRGAJSA-N Glu-Tyr-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(O)=O)CC1=CC=C(O)C=C1 RXJFSLQVMGYQEL-IHRRRGAJSA-N 0.000 description 1
- BGVYNAQWHSTTSP-BYULHYEWSA-N Gly-Asn-Ile Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BGVYNAQWHSTTSP-BYULHYEWSA-N 0.000 description 1
- KQDMENMTYNBWMR-WHFBIAKZSA-N Gly-Asp-Ala Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O KQDMENMTYNBWMR-WHFBIAKZSA-N 0.000 description 1
- MOJKRXIRAZPZLW-WDSKDSINSA-N Gly-Glu-Ala Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O MOJKRXIRAZPZLW-WDSKDSINSA-N 0.000 description 1
- ITZOBNKQDZEOCE-NHCYSSNCSA-N Gly-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)CN ITZOBNKQDZEOCE-NHCYSSNCSA-N 0.000 description 1
- MHXKHKWHPNETGG-QWRGUYRKSA-N Gly-Lys-Leu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O MHXKHKWHPNETGG-QWRGUYRKSA-N 0.000 description 1
- NGRPGJGKJMUGDM-XVKPBYJWSA-N Gly-Val-Gln Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O NGRPGJGKJMUGDM-XVKPBYJWSA-N 0.000 description 1
- BAYQNCWLXIDLHX-ONGXEEELSA-N Gly-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN BAYQNCWLXIDLHX-ONGXEEELSA-N 0.000 description 1
- MDBYBTWRMOAJAY-NHCYSSNCSA-N His-Asn-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CN=CN1)N MDBYBTWRMOAJAY-NHCYSSNCSA-N 0.000 description 1
- IGBBXBFSLKRHJB-BZSNNMDCSA-N His-Lys-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CN=CN1 IGBBXBFSLKRHJB-BZSNNMDCSA-N 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 101000953492 Homo sapiens Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1 Proteins 0.000 description 1
- 101001052490 Homo sapiens Mitogen-activated protein kinase 3 Proteins 0.000 description 1
- KFVUBLZRFSVDGO-BYULHYEWSA-N Ile-Gly-Asp Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O KFVUBLZRFSVDGO-BYULHYEWSA-N 0.000 description 1
- JZNVOBUNTWNZPW-GHCJXIJMSA-N Ile-Ser-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)N JZNVOBUNTWNZPW-GHCJXIJMSA-N 0.000 description 1
- RMJWFINHACYKJI-SIUGBPQLSA-N Ile-Tyr-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N RMJWFINHACYKJI-SIUGBPQLSA-N 0.000 description 1
- 102100037739 Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1 Human genes 0.000 description 1
- 108010015268 Integration Host Factors Proteins 0.000 description 1
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 1
- LOLUPZNNADDTAA-AVGNSLFASA-N Leu-Gln-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O LOLUPZNNADDTAA-AVGNSLFASA-N 0.000 description 1
- KGCLIYGPQXUNLO-IUCAKERBSA-N Leu-Gly-Glu Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O KGCLIYGPQXUNLO-IUCAKERBSA-N 0.000 description 1
- VBZOAGIPCULURB-QWRGUYRKSA-N Leu-Gly-His Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N VBZOAGIPCULURB-QWRGUYRKSA-N 0.000 description 1
- QNTJIDXQHWUBKC-BZSNNMDCSA-N Leu-Lys-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O QNTJIDXQHWUBKC-BZSNNMDCSA-N 0.000 description 1
- DPURXCQCHSQPAN-AVGNSLFASA-N Leu-Pro-Pro Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DPURXCQCHSQPAN-AVGNSLFASA-N 0.000 description 1
- HGLKOTPFWOMPOB-MEYUZBJRSA-N Leu-Thr-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 HGLKOTPFWOMPOB-MEYUZBJRSA-N 0.000 description 1
- QESXLSQLQHHTIX-RHYQMDGZSA-N Leu-Val-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QESXLSQLQHHTIX-RHYQMDGZSA-N 0.000 description 1
- QQUJSUFWEDZQQY-AVGNSLFASA-N Lys-Gln-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CCCCN QQUJSUFWEDZQQY-AVGNSLFASA-N 0.000 description 1
- SKRGVGLIRUGANF-AVGNSLFASA-N Lys-Leu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SKRGVGLIRUGANF-AVGNSLFASA-N 0.000 description 1
- OIQSIMFSVLLWBX-VOAKCMCISA-N Lys-Leu-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OIQSIMFSVLLWBX-VOAKCMCISA-N 0.000 description 1
- WINFHLHJTRGLCV-BZSNNMDCSA-N Lys-Tyr-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CC=C(O)C=C1 WINFHLHJTRGLCV-BZSNNMDCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 102100024192 Mitogen-activated protein kinase 3 Human genes 0.000 description 1
- 241000207746 Nicotiana benthamiana Species 0.000 description 1
- RBRNEFJTEHPDSL-ACRUOGEOSA-N Phe-Phe-Lys Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 RBRNEFJTEHPDSL-ACRUOGEOSA-N 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- CYQQWUPHIZVCNY-GUBZILKMSA-N Pro-Arg-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O CYQQWUPHIZVCNY-GUBZILKMSA-N 0.000 description 1
- OBVCYFIHIIYIQF-CIUDSAMLSA-N Pro-Asn-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O OBVCYFIHIIYIQF-CIUDSAMLSA-N 0.000 description 1
- UTAUEDINXUMHLG-FXQIFTODSA-N Pro-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1 UTAUEDINXUMHLG-FXQIFTODSA-N 0.000 description 1
- NMELOOXSGDRBRU-YUMQZZPRSA-N Pro-Glu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1 NMELOOXSGDRBRU-YUMQZZPRSA-N 0.000 description 1
- UREQLMJCKFLLHM-NAKRPEOUSA-N Pro-Ile-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O UREQLMJCKFLLHM-NAKRPEOUSA-N 0.000 description 1
- KHRLUIPIMIQFGT-AVGNSLFASA-N Pro-Val-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O KHRLUIPIMIQFGT-AVGNSLFASA-N 0.000 description 1
- ZMLRZBWCXPQADC-TUAOUCFPSA-N Pro-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 ZMLRZBWCXPQADC-TUAOUCFPSA-N 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- IYCBDVBJWDXQRR-FXQIFTODSA-N Ser-Ala-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(O)=O IYCBDVBJWDXQRR-FXQIFTODSA-N 0.000 description 1
- NLQUOHDCLSFABG-GUBZILKMSA-N Ser-Arg-Arg Chemical compound NC(N)=NCCC[C@H](NC(=O)[C@H](CO)N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O NLQUOHDCLSFABG-GUBZILKMSA-N 0.000 description 1
- QEDMOZUJTGEIBF-FXQIFTODSA-N Ser-Arg-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O QEDMOZUJTGEIBF-FXQIFTODSA-N 0.000 description 1
- RJHJPZQOMKCSTP-CIUDSAMLSA-N Ser-His-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(O)=O RJHJPZQOMKCSTP-CIUDSAMLSA-N 0.000 description 1
- PPNPDKGQRFSCAC-CIUDSAMLSA-N Ser-Lys-Asp Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPNPDKGQRFSCAC-CIUDSAMLSA-N 0.000 description 1
- XVWDJUROVRQKAE-KKUMJFAQSA-N Ser-Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CC1=CC=CC=C1 XVWDJUROVRQKAE-KKUMJFAQSA-N 0.000 description 1
- PMTWIUBUQRGCSB-FXQIFTODSA-N Ser-Val-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O PMTWIUBUQRGCSB-FXQIFTODSA-N 0.000 description 1
- IAOHCSQDQDWRQU-GUBZILKMSA-N Ser-Val-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O IAOHCSQDQDWRQU-GUBZILKMSA-N 0.000 description 1
- PCMZJFMUYWIERL-ZKWXMUAHSA-N Ser-Val-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O PCMZJFMUYWIERL-ZKWXMUAHSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- DFTCYYILCSQGIZ-GCJQMDKQSA-N Thr-Ala-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O DFTCYYILCSQGIZ-GCJQMDKQSA-N 0.000 description 1
- CAGTXGDOIFXLPC-KZVJFYERSA-N Thr-Arg-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CCCN=C(N)N CAGTXGDOIFXLPC-KZVJFYERSA-N 0.000 description 1
- GNHRVXYZKWSJTF-HJGDQZAQSA-N Thr-Asp-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N)O GNHRVXYZKWSJTF-HJGDQZAQSA-N 0.000 description 1
- KRPKYGOFYUNIGM-XVSYOHENSA-N Thr-Asp-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N)O KRPKYGOFYUNIGM-XVSYOHENSA-N 0.000 description 1
- URPSJRMWHQTARR-MBLNEYKQSA-N Thr-Ile-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O URPSJRMWHQTARR-MBLNEYKQSA-N 0.000 description 1
- KZSYAEWQMJEGRZ-RHYQMDGZSA-N Thr-Leu-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O KZSYAEWQMJEGRZ-RHYQMDGZSA-N 0.000 description 1
- LVRFMARKDGGZMX-IZPVPAKOSA-N Thr-Tyr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CC1=CC=C(O)C=C1 LVRFMARKDGGZMX-IZPVPAKOSA-N 0.000 description 1
- XGFYGMKZKFRGAI-RCWTZXSCSA-N Thr-Val-Arg Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N XGFYGMKZKFRGAI-RCWTZXSCSA-N 0.000 description 1
- 101710111490 Transcription factor VIP1 Proteins 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- IKUMWSDCGQVGHC-UMPQAUOISA-N Trp-Pro-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC2=CNC3=CC=CC=C32)N)O IKUMWSDCGQVGHC-UMPQAUOISA-N 0.000 description 1
- QUILOGWWLXMSAT-IHRRRGAJSA-N Tyr-Gln-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O QUILOGWWLXMSAT-IHRRRGAJSA-N 0.000 description 1
- XQYHLZNPOTXRMQ-KKUMJFAQSA-N Tyr-Glu-Arg Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O XQYHLZNPOTXRMQ-KKUMJFAQSA-N 0.000 description 1
- RWOKVQUCENPXGE-IHRRRGAJSA-N Tyr-Ser-Arg Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O RWOKVQUCENPXGE-IHRRRGAJSA-N 0.000 description 1
- WQOHKVRQDLNDIL-YJRXYDGGSA-N Tyr-Thr-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O WQOHKVRQDLNDIL-YJRXYDGGSA-N 0.000 description 1
- 101710117021 Tyrosine-protein phosphatase YopH Proteins 0.000 description 1
- YFOCMOVJBQDBCE-NRPADANISA-N Val-Ala-Glu Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N YFOCMOVJBQDBCE-NRPADANISA-N 0.000 description 1
- COYSIHFOCOMGCF-UHFFFAOYSA-N Val-Arg-Gly Natural products CC(C)C(N)C(=O)NC(C(=O)NCC(O)=O)CCCN=C(N)N COYSIHFOCOMGCF-UHFFFAOYSA-N 0.000 description 1
- CVUDMNSZAIZFAE-TUAOUCFPSA-N Val-Arg-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N CVUDMNSZAIZFAE-TUAOUCFPSA-N 0.000 description 1
- UDNYEPLJTRDMEJ-RCOVLWMOSA-N Val-Asn-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)O)N UDNYEPLJTRDMEJ-RCOVLWMOSA-N 0.000 description 1
- JLFKWDAZBRYCGX-ZKWXMUAHSA-N Val-Asn-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N JLFKWDAZBRYCGX-ZKWXMUAHSA-N 0.000 description 1
- VFOHXOLPLACADK-GVXVVHGQSA-N Val-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)N VFOHXOLPLACADK-GVXVVHGQSA-N 0.000 description 1
- ROLGIBMFNMZANA-GVXVVHGQSA-N Val-Glu-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N ROLGIBMFNMZANA-GVXVVHGQSA-N 0.000 description 1
- HPANGHISDXDUQY-ULQDDVLXSA-N Val-Lys-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N HPANGHISDXDUQY-ULQDDVLXSA-N 0.000 description 1
- GTACFKZDQFTVAI-STECZYCISA-N Val-Tyr-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CC=C(O)C=C1 GTACFKZDQFTVAI-STECZYCISA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 108010005233 alanylglutamic acid Proteins 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 108010060035 arginylproline Proteins 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 239000000823 artificial membrane Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000030570 cellular localization Effects 0.000 description 1
- 230000002925 chemical effect Effects 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 108010042598 glutamyl-aspartyl-glycine Proteins 0.000 description 1
- 108010049041 glutamylalanine Proteins 0.000 description 1
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 1
- 108010072405 glycyl-aspartyl-glycine Proteins 0.000 description 1
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 108010015792 glycyllysine Proteins 0.000 description 1
- 108010087823 glycyltyrosine Proteins 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical class O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 108010057821 leucylproline Proteins 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 108010003700 lysyl aspartic acid Proteins 0.000 description 1
- 108010012988 lysyl-glutamyl-aspartyl-glycine Proteins 0.000 description 1
- 108010045397 lysyl-tyrosyl-lysine Proteins 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000001293 nucleolytic effect Effects 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 108010015796 prolylisoleucine Proteins 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 108010069117 seryl-lysyl-aspartic acid Proteins 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- -1 thiophene oxime Chemical class 0.000 description 1
- 108010061238 threonyl-glycine Proteins 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 108700004896 tripeptide FEG Proteins 0.000 description 1
- 239000005418 vegetable material Substances 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present invention relates to peptides comprising is made up of: the amino acid sequence or (ii) of (i) SEQ ID NO:1 has the amino acid sequence with amino acid sequence at least 80% sequence identity of SEQ ID NO:1 over the whole length.The invention further relates to conjugate, host cell, biological imaging systems, the method for visualizing internalization process, the method for being internalized by drug into cell and conjugates of the invention to be used as the purposes of drug or conjugate of the invention as investigational agent.
Description
Technical field
The present invention relates to peptides comprising or be made up of: the amino acid sequence or (ii) of (i) SEQ ID NO:1 is at it
There is the amino acid sequence with amino acid sequence at least 80% sequence identity of SEQ ID NO:1 in whole length.The present invention
It further relates to conjugate, host cell, biological imaging systems, the method for visualizing internalization process, be internalized by drug into cell
Method and conjugate of the invention are used as drug or investigational agent.
Background technique
Oncogenicity T-DNA and being transferred in plant cell in various plants by Agrobacterium tumefaciems (A.tumefacien)
On cause crown gall nodule (1-3).In laboratory conditions, which can be transferred to T-DNA in other eukaryon species, including ferment
The human cell (8) of female (4,5), fungi (6), algae (7) and culture.It has been developed as DNA delivery vector, DNA delivering
Carrier is widely used as genetic engineering (10) of the main force for plant (9) and non-plant organisms.
It is thin by being made of VirB/VirD4 during conversion (AMT) that Agrobacterium (Agrobacterium) is mediated
Bacterium IV type excretory system (T4SS), Agrobacterium tumefaciems into host cell (11,12) by T-DNA and bacterial virulence protein delivery.
Agrobacterium VirBA/VirD4T4SS is the typical case of T4SS race, is widely used by bacterium with by DNA (13,14) and protein
Macromolecular (15) transposition is to various bacteria and eukaryocyte (16).Agrobacterium T4SS device is made of 12 kinds of bacterial virulence albumen,
Including VirB1-11 and VirD4, they form the more subunit's transmembrane channels (17) being delivered to macromolecular in host cell.
Agrobacterium T4SS will at least 5 kinds of protein substrates be delivered in host cell;These include VirD2, VirD5,
VirE2, VirE3 and VirF (18-20).Evidence suggests these bacterium effectors are exported dependent on its C-terminal electrical signals
Into host cell (19).In delivering, these effector albumens act synergistically in host cell, and promote conversion process.
Have shown that host factor and these effectors interact, and most important (21) to successful conversion.
T-DNA is generated by the VirD2 albumen for playing endonuclease in bacterial cell, as from Ti-plasmids
Single-stranded (ss) DNA molecular (22-24).VirD2 keeps covalently being associated with the 5 ' ends of T-DNA, and passes through T4SS for this side
Formula imports in host cell (23).In host cell matter, then by the VirE2 of T4SS delivering, (it is exposed T-DNA
SsDNA binding protein) coating, it is formed T compound (25-27).VirD2 and VirE2 includes and host's input albumen α albumen phase
Functional core positioning signal (NLS) sequence (28) of interaction.They can act synergistically for T compound in host cell
Core input.
As a kind of effector albumen abundant being secreted into recipient cell, VirE2 during conversion process for being permitted
Other more processes are also vital.It is special that in vitro study shows that VirE2 forms valtage-gated and ssDNA on artificial membrane
Anisotropic channel shows that it may promote T-DNA to enter host cell (29).Due in the host cell matter VirE2 to cooperate
Mode and T chain combination, thus it can protect T-DNA from molten core degraded (nucleolytic degradation) (30,
31).As the main component of T compound, VirE2 transports the destiny that will affect T chain.
Verified VirE2 participate in two different ways the core target of T-DNA to.Firstly, in VirE2 molecule
Two independent NLS sequences are identified, are participated in direct mutual with arabidopsis (Arabidopsis) input albumen αisomer
It acts on (28).Secondly, VirE2 can also interact (32) with plant transcription factor VIP1;The host protein undergoes MAPK3 to be situated between
The phosphorylation and the core transposition infection induced by Agrobacterium led, this may cause the core input of VirE2, so as to cause T chain
Core inputs (33,34).
In host cell nuclear, VIP1 can interact with host's histone, and it is multiple that this interaction is advantageously possible for T
Close object targeting host's chromatin (34).In addition, VirE2 can interact with another host protein VIP2, VIP2 is a kind of
The transcription inhibitory factor of presumption is located at plant nucleolus (35).Stable conversion to the needs of VIP2 show VirE2 and VIP2 it
Between interaction T chain may be promoted to be integrated into host genome (35).
Therefore, in drug development and life science, molecule or drug targeting to intracellular specific position is made to be
It is important and challenging.In the presence of the constant demand to technology, these technologies are conducive to introduce molecule or drug passes through cell
Plasma membrane enters in cell, and is introduced into specific desired position.
Detailed description of the invention
When in conjunction with non-limiting example and attached drawing to consider, the present invention is better understood with reference to detailed description.
Fig. 1 shows VirE2 and the host plasma membrane of Agrobacterium delivering and being associated with for endocytosis film bubble.(A) between different time
Every the intracellular VirE2 of detection Ben Saimushi tobacco (N.benthamiana).Agrobacterium tumefaciems EHA105virE2::GFP11 quilt
It penetrates into transgenosis Ben Saimushi tobacco (Nb308A) leaf of expression GFP1-10 and DsRed.32 hours after agroinfiltration
The Z image series of projection were obtained with 48 hours.(B) cytoplasm of the VirE2 in the tobacco cell contacted with Agrobacterium tumefaciens cell
It is accumulated at side.The Agrobacterium tumefaciens strain EHA105virE2::GFP11 (pGFP 1-10 and pVBA-RFP) marked with DsRed
(it can also deliver VirE2-GFP11 and express the T-DNA of GFP1-10) penetrates into wild type Ben Saimushi Tobacco Leaf.In agriculture bar
2 days acquisition images after bacterium is penetrated into.(C) VirE2 of Agrobacterium delivering is accumulated at host plasma membrane.With mixed uniformly crown gall agriculture bar
Bacteria strain EHA105virE2::GFP11 (pGFP1-10) (it can deliver VirE2-GFP11 and express the T-DNA of GFP1-10)
And (it can deliver VirE2-GFP11 and express the T- of plasma membrane (PM) tracker EHA105virE2::GFP11 (pm-rb)
DNA wild type Ben Saimushi Tobacco Leaf) is penetrated into.2 days acquisition images after agroinfiltration.(D) agriculture bar in Tobacco Epidermis
The plasma membrane (above) of VirE2 and the FM4-64 label of bacterium delivering or the common location of endocytosis film bubble (following figure).With Agrobacterium tumefaciems bacterium
Strain EHA105virE2::GFP11 (pGFP 1-10) penetrates into wild type Ben Saimushi Tobacco Leaf, is then dyed with FM4-64.In agriculture
2 days acquisition images after bacillus is penetrated into.Scale bar, 10 μm.
Fig. 2 shows that Agrobacterium accumulates at the space between cells of the leaf epidermal cell of infiltration.(A) crown gall marked with GFP
The Z series of the projection of Ben Saimushi tobacco (Nb308A) leaf that agrobatcerium cell EHA105 (pVB-GFP) penetrates into.With Olympic
Under the Laser Scanning Confocal Microscope of Bath UAPO N 340 40 × N.A.1.15 water immersion objective, schemed within 2 days after agroinfiltration
Picture.White line is added in image, indicates the boundary between leaf epidermal cell.(B) the crown gall agriculture marked with mixed uniformly GFP
The wild type that the Agrobacterium tumefaciens cell EHA105 (pVB-RFP) of bacilli-cell EHA105 (pVB-GFP) and DsRed label penetrates into
The Z series of the projection of Ben Saimushi Tobacco Leaf.Scale bar, 20 μm.
Fig. 3 shows total movement of the endocytosis film bubble of VirE2 and FM4-64 label in Ben Saimushi Tobacco Epidermis.
Wild type Ben Saimushi Tobacco Leaf is penetrated into Agrobacterium tumefaciens cell EHA105virE2::GFP11 (pGFP1-10), is then carried out
FM4-64 dyeing.2 days acquisition images after agroinfiltration.Scale bar, 20 μm.
Fig. 4 shows that the interference to host's endocytosis compromises VirE2 and transports and reduce its virulence.(A) defective
The expression of clathrin Hub compromise VirE2 and leave plasma membrane.With Agrobacterium tumefaciens strain EHA105virE2::GFP11
(pXY01) or EHA105virE2::GFP11 (pXY01-Hub) (its can deliver VirE2-GFP11 and express Hub T-DNA)
Penetrate into Ben Saimushi tobacco (Nb308A) leaf.The Z image series of projection are obtained within 4 days after agroinfiltration.Scale bar, 20 μm.
(B) VirE2-GFP for being retained in host cell boundary is measured in each imageCompoundThe intensity of signal, n: the image of measurement
Quantity.(C) ES1 processing reduces the core accumulation of VirE2 in plant epidermis cell.Individually with EHA105virE2::GFP11 or with
ES1 penetrates into Ben Saimushi tobacco (Nb308A) leaf together.Amplify blocked areas to protrude nucleus.2 days after agroinfiltration
Obtain the Z image series of projection.Scale bar, 20 μm.(D) VirE2-GFP is measured in each host cell nuclearCompoundSignal it is strong
Degree, n: the nucleus amount of measurement.(E) ES1 or tyrphostin A23 processing reduces swollen on arabidopsis root
Tumor occurs.Chemically treated arabidopsis root and agrobacterium strains A348 are co-cultured, and are used for tumour.(F) tumour forms frequency
Quantify.P < 0.01 * (non-matching T inspection).
Fig. 5 shows that the expression of Hub compromises FM4-64 in Ben Saimushi Tobacco Epidermis and absorbs.(A) crown gall agriculture is used
Bacilli-cell EHA105 (pXY01) or EHA105 (pXY01-Hub) penetrates into wild type Ben Saimushi Tobacco Leaf, then in Agrobacterium
Progress FM4-64 dyeing in 2nd day or the 4th day after infiltration.5 hours after dyeing, with Olympus UAPO N 34040 ×
Under the Laser Scanning Confocal Microscope of N.A.1.15 water immersion objective, the Z image series of projection are obtained.Scale bar, 20 μm.(B) FM4-64 takes the photograph
What is taken quantifies.The number (n=20) of the endocytosis film bubble of FM4-64 dyeing is calculated in each image.(the non-matching T inspection of p < 0.01 *
It tests).
Fig. 6 shows that the expression of the clathrin Hub of dominant negative effect compromises VirE2 in Ben Saimushi Tobacco Epidermis
Leave plasma membrane.(A) wild type Ben Saimushi tobacco is penetrated into Agrobacterium tumefaciens cell EHA105virE2::GFP11 (pXY01)
Leaf.(B) wild type Ben Saimushi Tobacco Leaf is penetrated into Agrobacterium tumefaciens cell EHA105virE2::GFP11 (pXY01-Hub).
Show the Z image series of projection.Scale bar, 20 μm.
Fig. 7 shows that ES1 processing influences early endosome and VirE2 transport.(A) ES1 processing leads to Ben Saimushi Tobacco Leaf
The aggregation of inner body in epidermal cell comprising SYP61.Individually with Agrobacterium tumefaciens cell EHA105 (pXY01-SYP61-mC) or
It is mixed with ES1 (25 μM) and penetrates into wild type Ben Saimushi Tobacco Leaf.In control, the SYP61-mCherry of transient expression is marked
Round early endosome in Ben Saimushi Tobacco Epidermis.Aggregation (the arrow of inner body of the ES1 processing induction comprising SYP61
It is shown).(B) aggregation of the inner body comprising SYP61 limits the transport of the VirE2 in Ben Saimushi Tobacco Epidermis.With uniform
Mixed Agrobacterium tumefaciens cell EHA105virE2::GFP11 (pGFP1-10) and EHA105virE2::GFP11 (pXY01-
SYP61-mC wild type Ben Saimushi Tobacco Leaf) is penetrated into together with chemical effect object ES1.It obtains within the 2nd day after agroinfiltration
The Z image series of projection.Scale bar, 20 μm.
Fig. 8 shows that the mutation at VirE2 endocytosis motif affects VirE2 and is internalized by and compromises turning for mediated by agriculture bacillus
Change.(A) exemplary locations of the endocytosis motif of VirE2 presumption are reflected by the eukaryon linear motif resource of functional site in protein
Fixed (www.ELM.eu.org).The constant amino acid tag of endocytosis motif is red.(B) in double endocytosis motifs of the end VirE2C
The mutation at place influences VirE2 and is internalized by into host cell.With Agrobacterium tumefaciems EHA105virE2::GFP11 or include alanine
The mutant strain of corresponding tyrosine is replaced to penetrate into Ben Saimushi tobacco (Nb308A) leaf.It obtains within the 2nd day after agroinfiltration
The Z image series of projection.Scale bar, 20 μm.(C) percentage of the VirE2 rested at cell boundaries is expressed as, thin with host
The relevant VirE2-GFP in born of the same parents boundaryCompoundIntensity divided by the overall strength in each image, n: the quantity of the image of measurement.(D) exist
Mutation at double endocytosis motifs of the end VirE2C reduces instantaneous conversion efficiency.With Agrobacterium tumefaciems EHA105 or include binary
The mutant strain of carrier pQH121-mC (the free mCherry of CaMV 35S promoter control in T-DNA) penetrates into wild type sheet
Fill in Mu Shi Tobacco Leaf.Under the Laser Scanning Confocal Microscope with Olympus UPL SAPO N 10 × N.A.0.40 object lens, in agriculture bar
Bacterium obtains the Z image series of projection for 2 days after penetrating into.The single opticator of light field is shown, with indicator cells shape (following figure).
Scale bar, 50 μm.(E) intensity of the mCherry of transient expression, n: the quantity of the image of measurement are measured in each image.(F)
Mutation at double endocytosis motifs of the end VirE2C reduces stable transformation efficiency.Agrobacterium tumefaciems A348 and mutant strain
It is formed and is measured for tumour.(G) tumour forms quantifying for frequency.* p < 0.01 p < 0.05, * * (non-matching T inspection).
Fig. 9 shows that the mutation at the VirE2 endocytosis sorting motif of other presumptions does not influence the VirE2 in host cell
Internalization.Ben Saimushi tobacco (Nb308A) leaf is penetrated into Agrobacterium tumefaciems EHA105virE2::GFP11 or VirE2 mutant,
In corresponding tyrosine residue or leucine residue replaced by alanine.The Z series of drawing of projection is obtained within 2 days after agroinfiltration
Picture.Scale bar, 20 μm.
Figure 10 shows the sequence alignment analysis of the VirE2 from different types of Ti-plasmids.Sequence alignment shows coming
From the VirE2 albumen of different types of Ti-plasmids, the endocytosis motif of double tyrosine-baseds is conservative at C-terminal.
Figure 11 is shown to be weakened in the interaction of endocytosis motif and plant AP2M and ap2m mutation of the end VirE2C
Tumour generation.(A) VirE2C terminal tail and AP2M interact.VirE2C terminal tail (the GST- that will be fused on GST
VirE2C) for being pulled down (pull-down) test in vitro, AP2M loading (cargo) binding structural domain is fused on MBP
(MBP-AP2MC).Input (following figure) part of (above) and 20% is pulled down by western blot analysis.Free MBP and
MBP-AP2MC fusion protein adds asterisk.(B) double mutation at double endocytosis motifs eliminate VirE2C terminal tail and AP2M is carried
Interaction between object binding structural domain.Input (following figure) portion of (above) and 20% is pulled down by western blot analysis
Point.The fusion of MBP-AP2MC adds asterisk.(C) in root conversion test, arabidopsis ap2m-1 and ap2m-2 mutation reduce tumour hair
It is raw.(D) tumour forms quantifying for frequency.P < 0.01 * (non-matching T inspection).PD: drop-down;IB: immunoblotting.
Specific embodiment
It is an object of the invention to meet the Compounds and methods for of molecular targeted specific cells position by providing
Above-mentioned needs., it is surprising that inventor has found that the internalization of VirE2 is the particular sequence motif as described in SEQ ID NO:1
It mediates.The conjugation of the motif and other molecular radicals (such as drug) will mediate the internalization of conjugate.In addition, the motif allows
It establishes visualization internalization and drug is internalized by the method into cell.
In a first aspect, present invention is accordingly directed to peptides comprising or be made up of: the amino acid of (i) SEQ ID NO:1
Sequence or (ii) have the amino with amino acid sequence at least 80% sequence identity of SEQ ID NO:1 over the whole length
Acid sequence.
In the various embodiments of the present invention, the length of the peptide is 10 to 200 amino acid.In alternate embodiment
In, peptide of the invention is by being no more than 500 amino acid, no more than 450 amino acid, no more than 400 amino acid, being no more than
350 amino acid are no more than 300 amino acid, are no more than 250 amino acid, are no more than 200 amino acid, are no more than 150
Amino acid is no more than 100 amino acid, is no more than 80 amino acid, is no more than 50 amino acid or is no more than 30 amino acid
Composition.In other embodiments, the length of the peptide is 10 to 100 amino acid, length is 15 to 130 amino acid, length
Degree is 20 to 170 amino acid or length is 30 to 210 amino acid.
The scope of the present invention further includes various embodiments, wherein amino acid sequence has and SEQ over the whole length
The amino acid sequence of ID NO:1 at least 85%, at least 87%, at least 90%, at least 93%, at least 95%, at least 97% or extremely
Few 99% sequence identity.
On the other hand, the present invention relates to conjugates comprising peptide of the invention, wherein the peptide further includes at least one
Funtion part.
In the various embodiments of the present invention, the N-terminal of at least one described funtion part and the peptide is conjugated.
The scope of the present invention further includes various embodiments, wherein the end the C of at least one described funtion part and the peptide
End conjugation.
In the various embodiments of above-mentioned aspect, at least one described funtion part does not include described in SEQ ID NO:2
Amino acid sequence or its C-terminal segment.
On the other hand, the present invention relates to conjugate of the invention, it is specified that at least one described funtion part does not include SEQ
Amino acid sequence described in ID NO:3 or its N-terminal segment.
In the various embodiments of the present invention, wherein funtion part is pharmaceutically or biologically active ingredient
Object.
The scope of the present invention further includes various embodiments, and wherein funtion part further includes or green fluorescent protein
(GFP) or its segment.
In the various embodiments of the present invention, the conjugate further includes at least one for translocating to the portion in cell
Point.In a more preferred embodiment, the part for translocating in cell is the C-terminal sequence of VirE2.Even more
In preferred embodiment, the part for translocating in cell includes R-X(7)The sequence of-R-X-R-X-R-X-X or by
R-X(7)The sequence of-R-X-R-X-R-X-X forms, and wherein X is any Proteinogenic amino acids, and R is arginine.In addition preferred
In embodiment, the part for translocating in cell is cell-penetrating peptides or reagent.
In the third aspect, the present invention relates to a kind of carriers comprising encodes the nucleotide sequence of peptide of the invention.
On the other hand, the present invention relates to a kind of host cells comprising carrier of the invention.
At the 5th aspect, the present invention relates to the biological imaging systems for visualizing internalization comprising (a) is of the invention to be sewed
Object is closed, is conjugated with the first GFP segment;(b) cell expresses the 2nd GFP segment, wherein the first GFP segment and the 2nd GFP
Segment can assemble to form functional GFP.
In the various embodiments of the present invention, the conjugate of (a) (a) is conjugated with according to the peptide of SEQ ID NO:5;With/
Or (b) cell expresses the peptide according to SEQ ID NO:6.
The scope of the present invention further includes various embodiments, wherein cell be selected from by plant cell, yeast cells, fungi,
The group of the mammalian cell of algae or culture composition.In preferred embodiments, cell is plant cell.
In the various embodiments of above-mentioned aspect, it is multiple that cell expresses relevant adapter (adaptor) AP2 of clathrin
Fit (AP2M).
On the other hand, the present invention relates to a kind of methods for visualizing internalization process comprising: it (a) provides of the invention
Biological imaging systems;(b) conjugate is made to be in contact with cell.
At the 7th aspect, the present invention relates to be internalized by drug to intracellular method comprising: it (a) provides of the invention
Conjugate and cell;(b) conjugate is made to be in contact with cell.
At the 18th aspect, the present invention relates to conjugates of the invention to be used as drug.
Purposes in terms of the last one, the present invention relates to conjugate of the invention as investigational agent.
As used herein, "at least one" is related to one or more, and particularly 1,2,3,4,5,6,7,8,9,10 or more
It is a.
Example
Material and method
Bacterial strain, plasmid and growth conditions
Bacterium bacterial strain used in this research and plasmid are listed in table 1.Agrobacterium tumefaciens strain is at 28 DEG C in LB
(Luria-Bertani) it is grown in culture medium.When necessary, 100 μ g ml are supplemented in the medium-1Carbenicillin or 50 μ g
ml-1Kanamycins.
Vegetable material
Arabidopsis (environmental, Colombia -0) wild type and mutant plant are used in root conversion test.AP2M insertion
Mutant, ap2m-1 (SALK_083693) and ap2m-2 (CS807972) obtained from Ohio State University arabidopsis
Biological Resource Center.
Ben Saimushi benthamiana wild-type and transgenosis system Nb308A (expression GFP1-10 are used in agroinfiltration test
And DsRed) (36).
Construct
GFP1-10 construct
In order to construct the binary vector (pXY01) for expression of target gene in plant cell, with 5 '-CTAGTCT of primer sets
AGACCCGGGCTCGAGCCATGGGGATCCGAGCTCGAATTTCCCCGATCGTTCAAACATTTGGCA ATAAAGTTT-3’
Binary vector skeleton is expanded from plasmid er-gb (37) with 5 '-CTAGTCTAGAGCTAGCTCCGGACTTAAGA, to generate DNA piece
Section, wherein ER marker box is replaced by multiple cloning sites sequence;Then PCR product is digested with XbaI, and self connection is to generate
Binary vector pXY01.
With primer 5 '-CTAGTCTAGAATGGTTTCGAAAGGCGAGGA-3 ' and 5 '-CGCGGATCCTTATTTCTCGTT
TGGGTCTTTGC-3 ' expands GFP1-10 coded sequence from pQH308A (36), and is inserted into pXY01 to generate pGFP1-10.
The construct of Agrobacterium label
With primer sets 5 '-ACGCGTCGACCTCGAGGGGGG-3 ' and 5 '-
ACGCGTCGACTCTCAGTAAAGCGCTGGCTG-3 ' expands skeleton (59) from pCB301;Then PCR product is digested with SalI,
And self connection, to generate pXY301, pXY301 lacks T-DNA right border sequence.With 5 '-ACGCGTCGACATGGGTTT of primer
ACAGACAGCGTAATCTC-3 ' and 5 '-ACCTTATCTCCTTAGCTCGCAAC-3 ' expands virB promoter from plasmid pTiA6
Area, and be cloned into pXY301 to generate pVB.With primer 5 '-CGGGGTACCATGGCCTCCTCCGAGGACG-3 ' and 5 '-
CGGGGTACCTTACAGGAACAGGTGGTGGCG-3 ' expands DsRed coded sequence, and is cloned into pVB to generate pVB-
RFP.With primer 5 '-CGGGGTACCATGTCTAAAGGTGAAGAATTATTCACTG-3 ' and 5 '-CGGGGTACCTTATTTGTA
CAATTCATCCATACCATG-3 ' expands GFP coded sequence, and is cloned into pVB to generate pVB-GFP.Then primer 5 '-is used
ATGCAATCATGATTCAAATATGTATCCGCTCAAGAGA-3 ' and 5 '-ATGCAATCATGACTCACGTTAAGGGATTTTG
GACAT-3 ' expands amicillin resistance box from pACT2 (Clontech), and is inserted into pVB-RFP and replaces kanamycins anti-
Property box is to generate pVBA-RFP.
Hub construct
With primer 5 '-TCCCCCCGGGATGAAGAAGTTTAACTTAAATGTTCAGGCTG-3 ' and 5 '-
C of the CGCGGATCCTTAGTAGCCGCCCATCGGT-3 ' from full arabidopsis cDNA prepared product amplification coding CHC1 (At3g1130)
The 1860bp DNA fragmentation of end section.PCR fragment is cloned into generate pXY01-Hub in carrier pXY01, wherein at Hub
Under the control of CaMV 35S promoter.
SYP61 construct
In order to mark early endosome, with primer 5 '-CTAGTCTAGAATGTCTTCAGCTCAAGATCCATTCT-3 ' and 5 '-
Overall length base of the CCGCTCGAGGGTCAAGAAGACAAGAACGAATAGG-3 ' from arabidopsis thaliana genomic dna amplification arabidopsis SYP61
It because of a group sequence (Atlg28490), and is cloned into binary vector pXY01, so that SYP61 is in the control of CaMV 35S promoter
Under.Then use primer 5 '-CCGCTCGAGGGAGGTGGCTCTGGCGGGGGATCAATGGTGAGCAAGGGCGAGGA-3 ' and 5 '-
CGCGGATCCTTACTTGTACAGCTCGTCCATGCCG-3 ' expands mCherry coded sequence, by PCR fragment at C-terminal gram
It is grand to generate pXY01-SYP61-mC.
Instantaneous mCherry expression construct
With primer 5 '-CCGCTCGAGATGGTGAGCAAGGGCGAGGA-3 ' and 5 '-CGGGGTACCTTACTTGTACAGC
TCGTCCATGCCG-3 ' expands mCherry coded sequence, and is cloned into binary vector pQH121 to generate pQH121-mC,
Wherein mCherry is under the control of CaMV 35S promoter.
Pull down construct
With primer 5 '-CGCGGATCCTCACCATTTTCATCGAAGCCA-3 ' and 5 '-CTAGTCTAGATCAGCATCTGA
295 amino acid C-terminal loading binding structural domains of the TCTCGTAAGATCCC-3 ' from arabidopsis cDNA amplification μ 2- subunit
Coded sequence (AP2M);PCR fragment is cloned into carrier pMAL-c2x (knob Great Britain biotechnology) to generate pMBP-AP2MC.
With primer 5 '-CGCGGATCCATCGTCGCCGATCGCAA-3 ' and 5 '-
76 amino acid C-terminals of the CCGCTCGAGTCAAAAGCTGTTGACGCTTTG-3 ' from pTibo542 (EHA105) amplification VirE2
The coded sequence of tail portion;PCR fragment is cloned into vector pGEX -4T-1 (General Electric's Medical Group) to generate pGST-
VirE2C。
Agroinfiltration method
Agrobacterium tumefaciens cell is grown overnight in LB;Then culture is diluted in LB culture medium to 50 times, go forward side by side one
One-step growth 5-6 hours.Unless otherwise stated, collecting bacterium and being resuspended in water to OD600=1.0.It will be thin using syringe
Bacterium suspension penetrates into the downside of complete depletion of Ben Saimushi Tobacco Leaf.Then the plant of infiltration was placed in 22 DEG C at 16 hours
Under the dark photoperiod of illumination/8 hour.
The VirE2 of Agrobacterium delivering is detected in Ben Saimushi tobacco
Use the VirE2 (36) of the division GFP system detection Agrobacterium delivering.Use the Agrobacterium tumefaciems bacterium of label
Strain EHA105virE2::GFP11 expresses VirE2-GFP11 fusion in bacterium.Use transgenosis system Nb308A or use
Agrobacterium tumefaciens strain comprising binary plasmid pGFP1-10 carries out transient expression to express GFP1-10 in plant cell.
Detect plasmalemma of plant and early endosome
By separately including binary matter with the transient expression detection plasma membrane or early endosome, the bacterial strain of Agrobacterium tumefaciens strain
Grain pm-rb (37), binary plasmid pm-rb include the T-DNA or pXY01-SYP61-mC of coding plasma membrane markers object, pXY01-
SYP61-mC includes the T-DNA of coding early endosome marker SYP61.
FM4-64 dyeing
By in distilled water the FM4-64 (hero's life technology Co., Ltd, the U.S.) of 25 μM of concentration penetrate into Ben Saimushi
In the downside of Tobacco Leaf.1 hour shooting image after infiltration.
Transient transformation assay
By Agrobacterium tumefaciems EHA105 or comprising the mutant strain of pQH121-mC, with low concentration (OD600=0.005) it penetrates into
Into wild type Ben Saimushi Tobacco Leaf, pQH121-mC includes the T-DNA of coding mCherry.It obtains within 2 days after agroinfiltration
Image is obtained, and is used for Strength co-mputation.
Stable conversion test
Surface sterilizing is carried out to arabidopsis wild type or mutation seed (Colombia -0) using 15% bleaching agent solution, and
It is incubated for 2 days at 4 DEG C.Then seed is placed on cured 1/2 × MS culture medium and (is supplemented with 1% sucrose and 0.5g L-1MES,
PH 5.8) on, and be incubated for 10-12 days under the dark photoperiod of 16 hours illumination/8 hour in 22 DEG C.Single seedling will be come from
Root be cut into 3-5mm sections, and with 1ml concentration 1 × 108Cell/ml Agrobacterium tumefaciens cell (A348 or mutant) mixing, and
It is layered on cured 1/2 × MS plate.Then plate is incubated for 36 hours at 22 DEG C.Root segment is being included into 100 μ g ml-1Head
It compares, and is maintained at 22 DEG C 5-6 weeks on 1/2 × MS culture medium flat plate of spore thiophene oxime.
Chemical treatment
Agrobacterium tumefaciens cell is grown in water, and cell concentration is adjusted to OD600=0.5;ES1 is added to cell
In suspension, until final concentration of 25 μM.Then mixture is penetrated into Ben Saimushi Tobacco Leaf.As control, by crown gall agriculture bar
The suspension of bacterium cell in water individually penetrates into Ben Saimushi Tobacco Leaf.Then the plant of infiltration is placed in 22 DEG C small 16
Under the dark photoperiod of Shi Guangzhao/8 hour.
During stable conversion test, the arabidopsis root from single seedling is cut into 3-5mm sections, and with ES1 or junket
Propylhomoserin phosphorylation inhibitor A23 (Sigma) mixing, until ultimate density in water is respectively 60 μM or 50 μM, it then will mixing
Object is kept 3 hours in the dark.As control, water process root segment is only used.Then root segment is mixed with Agrobacterium tumefaciems, for such as
The upper root conversion test.
External drop-down test
Fusion protein is generated using BL21 (DE3) coli strain.The single colonie of cell is inoculated into LB meat soup,
Overnight growth at 37 DEG C.Then cell culture is diluted in fresh LB meat soup to OD600=0.1, and in 28 DEG C of regrowths
1.5 hours, until OD600=0.6.Then with the thio galactolipin glucosides (IPTG) of isopropyl ss-D-1- of ultimate density 1mM 28
Induced fusion protein expression 6 hours at DEG C.
By at 4 DEG C with 5000g be centrifuged 5 minutes harvest bacterial cells, and with pull down lysis buffer (50mM
TrisHCl, 50mM NaCl, pH 7.5) it washed once.Then cell is resuspended in comprising protease inhibitor cocktail
In the drop-down lysis buffer of (Nacalai Tesque), and carry out simple ultrasonic (20 seconds 12 times, 40% power).By
15 minutes removal cell fragments are centrifuged with 12000g at 4 DEG C.
On rotator, by the supernatant of bait protein (protein of MBP or MBP label) with 150 μ l amylose trees
Rouge (knob Great Britain biotechnology) is incubated for 3 hours at 4 DEG C.Then with drop-down washing buffer (50mM TrisHCl, 50mM
NaCl, 0.5%Triton X-100, pH 7.5) column scrubber 5 times.
The supernatant for preying on albumen (prey protein) (protein of GST label) is added to comprising fixed MBP mark
In the column of the bait protein of note, and it is incubated overnight on rotator in 4 DEG C.Then it with drop-down washing buffer column scrubber 5 times, uses
The protein of drop-down lysis buffer elution capture comprising 10mM maltose.
Immunoblotting is carried out with anti-MBP antibody (sc-809, Santa Cruz biotechnology) to detect the albumen of MBP label
Matter, and immunoblotting is carried out with anti-GST antibody (sc-459, Santa Cruz biotechnology) to detect the protein of GST label.
Laser Scanning Confocal Microscope
PerkinElmer over the horizon roating plate system (Ultra View Vox Spinning with EM-CCD camera
Disk system) it is used for Laser Scanning Confocal Microscope.Unless otherwise stated, 2 days observation agroinfiltrations after agroinfiltration
Ben Saimushi Tobacco Leaf.In order to observe leaf epidermis, the leaf texture of agroinfiltration is separated from Ben Saimushi tobacco plant,
And in the water immersed on the glass slide with coverslip.All images by3D rendering is analyzed at software 6.2.1
Reason.Unless otherwise stated, all images are in being total to Olympus UPLSAPO 60 × N.A.1.20 water immersion objective
It is obtained under focusing microscope.
Fluorescence intensity quantifies
Fluorescence intensity (http://rsbweb.nih.gov/ij/) is measured using ImageJ.
Statistical analysis
Quantitative data is indicated with the average value ± SEM from least three independent experiments.Where appropriate, being examined using non-matching T
Test the statistical difference between analysis group.Think that difference is significant when P < 0.05.
1., table experiments bacterial strain and plasmid used
Example 1: VirE2 and host plasma membrane is associated with when delivering
In order to make VirE2 delivering visualization, VirE2-GFP11 fusion is expressed in Agrobacterium tumefaciems, and thin in plant
GFP1-10 is expressed in born of the same parents.It, will be complementary by VirE2-GFP11 and GFP1-10 after VirE2-GFP11 is delivered in plant cell
The VirE2-GFP of generationCompoundFluorescence signal visualizes (36).
Firstly, observing that VirE2 is delivered in tobacco cell in early stage;Come using the bacterial strain EHA105 of no T-DNA
Avoid any potential complication caused by transporting due to T-DNA.Generate the Agrobacterium tumefaciems of VirE2-GFP11
EHA105virE2::GFP11 is penetrated into transgenosis Ben Saimushi tobacco (Nb308A) leaf of expression GFP1-10 and DsRed.?
Under Laser Scanning Confocal Microscope, VirE2 is detected in different time points and is delivered in tobacco cell.As shown in Figure 1A, in agroinfiltration
32 hours afterwards, a small amount of VirE2 began to appear in tobacco cell boundary (above).Over time, in cell boundaries
Observe more VirE2 in place;VirE2 signal becomes Filamentous.48 hours after agroinfiltration, most of tobacco cells are thin
VirE2 accumulation (Figure 1A following figure) is shown in karyon.Statistics indicate that VirE2 primarily occur ins tobacco cell boundary, then move
It is dynamic to enter in nucleus.
It is then determined that the extensive positioning of Agrobacterium tumefaciens cell within plant tissue.Construct bacterial cell, with
GFP is expressed under the control of virB promoter, therefore they are fluorescently labeled naturally during agroinfiltration.It is marked in GFP
Agrobacterium tumefaciens cell EHA105 (pAT-GFP) penetrate into Ben Saimushi Tobacco Leaf in after, observe that most of bacterial cells exist
(Fig. 2A) is arranged at the space between cells of the tobacco cell of agroinfiltration.Then the bacterial cell of GFP label and DsRed are marked
Bacterial cell uniformly mix;Mixture is penetrated into Ben Saimushi Tobacco Leaf;Observe bacterial cell at space between cells with
Separated individual cells close-packed arrays (Fig. 2 B).These show that the limited space between cells of Ben Saimushi Tobacco Epidermis is only capable of holding
Receive single bacterial cell, and space limitation may only allow the side of bacterium and host cell to be in close contact.
Then the relative positioning of Agrobacterium tumefaciens cell with the VirE2 being delivered in plant cell is determined.It is marked with DsRed
(it can also deliver VirE2- to the Agrobacterium tumefaciens strain EHA105virE2::GFP11 (pGFP1-10 and pVBA-RFP) of note
The T-DNA of GFP11 and expression GFP1-10) penetrate into wild type Ben Saimushi Tobacco Leaf.48 hours after agroinfiltration, VirE2
(Figure 1B) is accumulated in the cytoplasm side for the tobacco cell being in close contact with Agrobacterium tumefaciens cell.It is interesting that VirE2 is from bacterium
The two sides of cell are delivered in plant cell.This shows that VirE2 can be delivered to two adjacent hosts simultaneously by single bacterium
In cell.
In order to determine subcellular location of the VirE2 in host cell of Agrobacterium delivering, by by with delivering VirE2-
The T-DNA of the identical bacterial cell delivering of GFP11, the expression specificity plasmalemma of plant tracker (37) in plant cell.It was found that
The VirE2 of Agrobacterium delivering and the plasma membrane tracker common location (Fig. 1 C) of transient expression show that VirE2 and plant are thin in delivering
Cytoplasmic membrane is associated.
Example 2: the VirE2 of Agrobacterium delivering is associated with endocytosis film bubble
In order to study how the VirE2 of film combination is moved in cytoplasm, marked using fluorescence styryl dye FM4-64
Remember film, then monitoring dynamic (38).This dyestuff is lipophilic;In the place of its application, it can be with label film, but own
Film cannot be penetrated.The transportational process that the attribute will allow us to monitor the film of VirE2 combination.By Agrobacterium tumefaciems
EHA105virE2::GFP11 cell penetrates into Ben Saimushi Tobacco Leaf, to start VirE2 delivering;After 48 hours, then will
FM4-64 dyestuff penetrates into same area.As shown in figure iD, the plasma membrane common location (above) of VirE2 and FM4-64 label, mode
Similar to using plasma membrane tracker (Fig. 1 C).It is interesting that the endocytosis film bubble common location that VirE2 is also marked with FM4-64, from
Plasma membrane pinch off (Fig. 1 D following figure).
In addition, even if when FM4-64 label film bubble moved in cytoplasm when, VirE2 and FM4-64 label endocytosis film
The common location of bubble continues to (Fig. 3).Movement speed range is 0.4 to 2.1 μm/second, this and the inner body reported in previous research
Dynamics is consistent (39).Statistics indicate that the VirE2 being delivered on host plasma membrane can carry out cell internalizing using host's endocytosis
And Cytoplasm Activity.
Example 3: effective VirE2 transport needs endocytosis
Then, whether the internalization for having checked VirE2 albumen needs host's process of endocytosis.It is reported that plant endocytosis is made
It is that (40) are mediated by clathrin triskelion with process;The overexpression meeting of the C-terminal part of clathrin heavy chain (Hub)
Cause to act on clathrin-mediated endocytosis (CME) strong dominant negative interaction, clathrin heavy chain and clathrin light-chain
In conjunction with and consume clathrin light-chain (41-43).
Then we test the influence of the overexpression Hub in Ben Saimushi Tobacco Leaf;It is supervised using FM4-64 dyestuff
Survey general process of endocytosis.It was found that the transient expression of Hub significantly reduces FM4-64 dyestuff under CaMV 35S promoter
Internalization (Fig. 5).This shows that the endocytosis in Ben Saimushi Tobacco Epidermis can be influenced really using the dominant negative strategy of Hub
Mechanism.It is interesting that discovery Hub is overexpressed the accumulation (Fig. 4 A and B) for improving VirE2 at cell boundaries.Time course
Experiment shows that compared with the control, in the tobacco cell for being overexpressed Hub, VirE2 residence time at cell boundaries is longer
(Fig. 6).These show that VirE2 leaves plant cell membrane and needs functional clathrin and active CME process.
In order to confirm that host's endocytosis is important VirE2 transport, chemical inhibitor inscribe peptide is used
(endosidin) 1 (ES1) interferes process of endocytosis, because ES1 influences endocytosis approach and leads to early stage in arabidopsis
The aggregation (44) of inner body.Highly dynamic round early endosome (44,45) is marked using SYP61-mCherry;It is with ES1
Transient expression in the Ben Saimushi Tobacco Epidermis of processing.It was found that ES1 processing leads to the exception of SYP61-mCherry marker
Assemble (Fig. 7 A), shows the aggregation of early endosome in leaf epidermal cell.It is interesting that ES1 processing cause it is different in host cell matter
Normal VirE2 transport;Inner body aggregation cylinder accumulation (Fig. 7 B) that VirE2 is induced in ES1.This shows that ES1 interference host's endocytosis is made
With and to limit VirE2 mobile.
Then test ES1 to VirE2 core target to influence because have shown that before Agrobacterium delivering VirE2 with
Nuclear localization signal (NLS) dependence mode is effectively targeted to plant nucleolus (36).As shown in Fig. 4 C and D, the significant drop of ES1 processing
The core accumulation of VirE2 in low tobacco cell, and VirE2 is gathered at cell boundaries or in cytoplasm.This shows that ES1 influences
VirE2 is transported rather than the delivering of VirE2 or oligomerization.In short, these discoveries show that host's endocytosis is transported in cytoplasm
And the core target of VirE2 plays an important role in subsequent plant cell.
Example 4:AMT process needs endocytosis
In order to confirm the importance of endocytosis, chemical inhibitor is had studied to the shadow of Agrobacterium-medialed transformation (AMT)
It rings, because conversion process needs functionality VirE2.Using ES1 or tyrphostin A23, (it is also arabidopsis
CME inhibitor) processing arabidopsis root carry out tumour occur test (46).As shown in Fig. 4 E and F, with ES1 or tyrosine phosphatase
Change inhibitor A23 processing and is obviously reduced tumour generation.These the result shows that interference host's endocytosis can to weaken plant thin
The stable conversion of born of the same parents, this may be because the endocytosis blocked affects the movement of VirE2, to affect it in AMT
Effect.
Example 5:VirE2 transport needs double endocytosis motifs of the C-terminal tail of VirE2
Then, the loading VirE2 for how being selected as internalization process had studied.It is typically chosen the matter for internalization process
The relevant loading albumen of film depend on the cytoplasm side of loading protein by various host's adapters identify endocytosis signal (47,
48).After being delivered in host plant cell by T4SS, VirE2 may be with a kind of phase of host's adaptor protein at plasma membrane
Interaction.Sequence is analysis shows the endocytosis that VirE2 (accession number AAZ50538) includes 5 presumptions sorts motif (Fig. 8 A).
In order to test the importance that the motif of these presumptions transports VirE2, each two leucine base or tyrosine
The potential crucial leucine of the motif (49) of base or tyrosine residue sport alanine.In addition, constructing double-mutant, it is used for
The motif (Fig. 8 A) of two tyrosine-baseds of spatial proximity at C-terminal.Then the Agrobacterium delivering of every kind of mutant is tested
VirE2 cellular localization and distribution.The single mutation of the motif of double C-terminal tyrosine-baseds and double mutation do not affect VirE2 to
Host cell membrane delivers (Fig. 8 B and C);However, double mutation lead to the significantly higher levels of VirE2 accumulation (figure at film site
8C).Mutation at the endocytosis motif of other presumptions of VirE2 does not influence VirE2 delivering or internalization process (Fig. 9).The result shows that
The motif of double C-terminal tyrosine-baseds of presumption is important VirE2 transport.
Example 6:AMT needs double endocytosis motifs of the C-terminal tail of VirE2
In order to determine whether VirE2 function needs the motif of double C-terminal tyrosine-baseds, after AMT, on T-DNA
The transient expression of mCherry under the control of CaMV35S promoter is tested.It is expressed based on Fluorescence Intensity Assays mCherry,
Due to the VirE2 mutation at double C-terminal endocytosis signals.As shown in Fig. 8 D and E, single mutation at double C-terminal endocytosis signals and double
Mutation significantly reduces instantaneous AMT efficiency, although the influence of double mutation (Y488A/Y494A) is than single mutation Y494A, (it compares
Y488A can more influence function) it is more significant.These show that VirE2 function needs double C-terminal endocytosis signals, and the end VirE2
The last one endocytosis signal is even more important.
Sequence alignment analysis shows the endocytosis motif of double C-terminal tyrosine-baseds in the VirE2 albumen from different Ti-plasmids
On be it is conservative, show they in different agrobacterium strains guard effects (Figure 10).In addition, from virulent strain A348's
The mutation of these upper conserved motifs of VirE2 also reduces the formation (Fig. 8 F and G) of tumour on arabidopsis root segment.The result shows that being located at
The endocytosis signal of double tyrosine-baseds of the end VirE2C is all critically important for the VirE2 function of instantaneous and stable AMT process.
The endocytosis motif and plant AP2M of the end example 7:VirE2C interact
The above results make we assume that the endocytosis motif of double C-terminal tyrosine-baseds of VirE2 may be by clathrin correlation
Sorting protein identification because clathrin-mediated endocytosis mechanism is by being known as " the relevant sorting protein of clathrin "
One group of host's adapter promotes, and is responsible for endocytosis signal identification and loading combines (47,48).Wherein, adaptor protein 2 (AP-2)
The endocytosis signal of compound identification tyrosine-based is simultaneously (50) in connection by the C-terminal structural domain of μ-subunit (AP2M).
It potentially interacts to test VirE2 and AP-2 compound, has carried out external drop-down with its fusion protein and tried
It tests.As shown in Figure 11 A, when the C-terminal tail of VirE2 is fused on GST (GST-VirE2C), it with merge on MBP
The loading binding structural domain (MBP-AP2MC) of AP2M interacts.However, double mutation at the endocytosis signal of double tyrosine-baseds
Eliminate the interaction (Figure 11 B).These are the result shows that the sorting motif that AP2M passes through double tyrosine-baseds is identified and combined
VirE2C terminal tail.
Example 8:ap2m mutation weakens tumour
In order to further confirm importance of host AP-2 compound during AMT, the two of arabidopsis AP2M are tested
A insertion mutation body is used for tumour.As shown in Figure 11 C and D, compared with wild type control, two insertion mutations of AP-2M
Body all shows the tumour being obviously reduced and is formed.These demonstrate that host's AP-2 compound is strictly plant cell mediated by agriculture bacillus
Conversion required for.
The present invention widely and universally describes herein.Fall into the relatively narrow type of each of general disclosure and
Subgenus group also constitutes a part of the invention.This includes universal description of the invention, is limited with collateral condition or negative,
Any theme is removed from the kind, regardless of whether specifically describing the material being removed herein.Other embodiments
In following following claims.In addition, in the case where describing features or aspect of the invention according to marlcush group, art technology
Personnel are it will be recognized that therefore the present invention can also be described in the form of any single member of marlcush group or member subgroup.
The person skilled in the art will easily understand the present invention is very suitable for realizing the purpose, and mentioned by acquisition
Result and advantage and those are wherein intrinsic.In addition, it will be apparent to one skilled in the art that not
In the case where departing from the scope of the present invention and being spiritual, various substitutions and modifications can be carried out to invention disclosed herein.This paper institute
Composition, method, program, processing, molecule and the specific compound stated are presently preferred the representative of embodiment, preferred real
The scheme of applying is exemplary and is not intended as limitation of the scope of the invention.In the sheet as defined by the scope of the claims
In the scope of invention, those skilled in the art will expect variation therein and other purposes.In the present specification, previously public
The a part or common knowledge for being not construed as recognizing that this document is the prior art are listed or discussed to the file of cloth.
The present invention being described in detail herein suitably can lack any element not specifically disclosed herein, the feelings of limitation
Implement under condition.Thus, for example, term " includes ", "include", "comprise" etc. should be widely understood and unrestricted.Therefore, word
The variant of " comprising " or such as "comprising" or "comprising" will accordingly appreciate that imply to include described whole or whole group, but not arrange
Except any other whole or whole group.In addition, terms used herein and expression are used with the description of term, and not restrictive,
And it is not intended to any equivalent or part thereof shown in excluded using these terms and expressions with described feature, but is recognized
It arrives, in scope of the present invention, various modifications can be carried out.It should therefore be understood that although having passed through example
Property embodiment and optional feature specifically disclose the present invention, but those skilled in the art can be using disclosed herein hair
Bright modifications and variations, and these modifications and variations are considered as within the scope of the invention.
All references recited herein and the content of patent document are integrally incorporated by reference.
Bibliography
1.M.D.Chilton, M.H.Drummond, D.J.Merio, D.Sciaky, A.L.Montoya, M.P.Gordon,
E.W.Nester, Stable incorporation of plasmid DNA into higher plant cells:the
11,263 (1977) of molecular basis of crown gall tumorigenesis.Cell
2.P.Zambryski.M.Holsters, K.Kruger, A.Depicker, J.Schell, M.Van Montagu,
H.M.Goodman, Tumor DNA structure in plant cells transformed by
209,1385 (1980) of A.tumefaciens.Science
3.L.M.Albright, M.F.Yanofsky, B.Leroux, D.Q.Ma, E.W.Nester, Processing of
The T-DNA of Agrobacterium tumefaciens generates border nicks and linear,
Single-stranded T-DNA.J.Bacteriol.169,1046 (1987)
4.P.Bundock, A.den Dulk-Ras, A.Beijersbergen, P.J.Hooykaas, Trans-kingdom
T-DNA transfer from Agrobacterium tumefaciens to Saccharomyces
Cerevisiae.EMBO J.14,3206 (1995)
5.K.L.Piers.J.D.Heath, X.Liang, K.M.Stephens, E.W.Nester, Agrobacterium
Tumefaciens-mediated transformation of yeast.Proc.Natl.Acad.Sci.U.S.A.93,1613
(1996).
6.M.J.de Groot, P.Bundock, P.J.Hooykaas, A.G.Beijersbergen, Agrobacterium
Tumefaciens-mediated transformation of filamentous fungi.Nat.Biotechnol.16,
839(1998).
7.S.Kathiresan, A.Chandrashekar, G.A.Ravishankar, R.Sarada,
Agrobacterium-Mediated Transformation in the Green Alga Haematococcus
Pluvialis (Chlorophyceae, Volvocales) (1) .J.Phycol.45,642 (2009)
8.T.Kunik, T.Tzfira, Y.Kapulnik, Y.Gafni, C.Dingwall, V.Citovsky, Genetic
Transformation of HeLa cells by Agrobacterium.Proc.Natl.Acad.Sci.U.S.A.98,
1871(2001).
9.T.Tzfira, V.Citovsky, Agrobacterium-mediated genetic transformation
Of plants:biology and biotechnology.Curr.Opin.Biotechnol.17,147 (2006)
10.C.B.Michielse, P.J.Hooykaas, C.A.van den Hondel, A.F.Ram,
Agrobacterium-mediated transformation as a tool for functional genomics in
Fungi.Curr.Genet.48,1 (2005)
11.K.J.Fullner, J.C.Lara, E.W.Nester, Pilus assembly by Agrobacterium T-
273,1107 (1996) of DNA transfer genes.Science
12.E.Cascales, P.J.Christie, Definition of a bacterial type IV
304,1170 (2004) of secretion pathway for a DNA substrate.Science
13.A.Beijersbergen, A.D.Dulk-Ras, R.A.Schilperoort, P.J.Hooykaas,
Conjugative Transfer by the Virulence System of Agrobacterium
256,1324 (1992) of tumefaciens.Science
14.H.H.Low, F.Gubellini, A.Rivera-Calzada, N.Braun, S.Connery,
A.Dujeancourt, F.Lu, A.Redzej, R.Fronzes, E.V.Orlova, G.Waksman, Structure of a
508,550 (2014) of type IV secretion system.Nature
15.E.Cascales, P.J.Christie, The versatile bacterial type IV secretion
Systems.Nat.Rev.Microbiol.1,137 (2003)
16.V.Chandran Darbari, G.Waksman, Structural Biology of Bacterial Type
IV Secretion Systems.Annu.Rev.Biochem.84,603 (2015)
17.P.J.Christie, K.Atmakuri, V.Krishnamoorthy, S.Jakubowski, E.Cascales,
Biogenesis, architecture, and function of bacterial type IV secretion
Systems.Annu.Rev.Microbiol.59,451 (2005)
18.A.C.Vergunst.B.Schrammeijer, A.den Dulk-Ras, C.M.de Vlaam,
T.J.Regensburg-Tuink, P.J.Hooykaas, VirB/D4-dependent protein translocation
290,979 (2000) of from Agrobacterium into plant cells.Science
19.A.C.Vergunst, M.C.van Lier, A.den Dulk-Ras, T.A.Stuve, A.Ouwehand,
P.J.Hooykaas, Positive charge is an important feature of the C-terminal
transport signal of the VirB/D4-translocated proteins of Agrobacterium.Proc.
Natl.Acad.Sci.U.S.A.102,832 (2005)
20.B.Schrammeijer, A.den Dulk-Ras, A.C.Vergunst, E.Jurado Jacome,
P.J.Hooykaas, Analysis of Vir protein translocation from Agrobacterium
Tumefaciens using Saccharomyces cerevisiae as a model:evidence for transport
Of a novel effector protein VirE3.Nucleic Acids Res.31,860 (2003)
21.S.B.Gelvin, Plant proteins involved in Agrobacterium-mediated
Genetic transformation.Annu.Rev.Phytopathol.48,45 (2010)
25 bp of 22.K.Wang, L.Herrera-Estrella.M.Van Montagu, P.Zambryski, Right
terminus sequence of the nopaline T-DNA is essential for and determines
Direction of DNA transfefr from Agrobacterium to the plant genome.Cell 38,455
(1984).
23.M.F.Yanofsky, S.G.Porter, C.Young, L.M.Albright,
M.P.Gordon.E.W.Nester, The virD operon of Agrobacterium tumefaciens encodes a
47,471 (1986) of site-specific endonuclease.Cell
24.P.Scheiffele, W.Pansegrau, E.Lanka, Initiation of Agrobacterium
tumefaciens T-DNA processing.Purified proteins VirDl and VirD2 catalyze site-
and strand-specific cleavage of superhelical T-border DNA in
Vitro.J.Biol.Chem.270,1269 (1995)
25.P.J.Christie, J.E.Ward, S.C.Winans, E.W.Nester, The Agrobacterium
tumefaciens virE2 gene product is a single-stranded-DNA-binding protein that
Associates with T-DNA.J.Bacteriol.170,2659 (1988)
26.V.Citovsky, M.L.Wong, P.Zambryski, Cooperative interaction of
Agrobacterium VirE2 protein with single-stranded DNA:implications for the T-
DNA transfer process.Proc.Natl.Acad.Sci.U.S.A.86,1193 (1989)
27.P.Sen, G.J.Pazour, D.Anderson, A.Das, Cooperative binding of
Agrobacterium tumefaciens VirE2protein to single-stranded
DNA.J.Bacteriol.171,2573 (1989)
28.S.Bhattacharjee, L.Y.Lee, H.Oltmanns, H.Cao, Veena, J.Cuperus,
S.B.Gelvin, IMPa-4, an Arabidopsis importin alpha isoform, is preferentially
Involved in Agrobacterium-mediated plant transformation.Plant Cell 20,2661
(2008).
29.F.Dumas, M.Duckely, P.Pelczar, P.Van Gelder, B.Hohn, An Agrobacterium
VirE2 channel for transferred-DNA transport into plant cells.Proc.Natl.Acad.
Sci.U.S.A.98,485 (2001)
30.L.Rossi, B.Hohn, B.Tinland, Integration of complete transferred DNA
units is dependent on the activity of virulence E2protein of Agrobacterium t
Umefaciens.Proc.Natl.Acad.Sci.U.S.A.93,126 (1996)
31.V.M.Yusibov, T.R.Steck, V.Gupta, S.B.Gelvin, Association of single-
stranded transferred DNA from Agrobacterium tumefaciens with tobacco cells.P
Roc.Natl.Acad.Sci.U.S.A.91,2994 (1994)
32.T.Tzfira, M.Vaidya, V.Citovsky, VIP1, an Arabidopsis protein that
Interacts with Agrobacterium VirE2, is involved in VirE2 nuclear import and
Agrobacterium infectivity.EMBO J.20,3596 (2001)
33.A.Djamei, A.Pitzschke, H.Nakagami, I.Rajh, H.Hirt, Trojan horse
Strategy in Agrobacterium transformation:abusing MAPK defense
318,453 (2007) of signaling.Science
34.J.Li, A.Krichevsky, M.Vaidya, T.Tzfira, V.Citovsky, Uncoupling of the
functions of the Arabidopsis VIP1 protein in transient and stable plant
Genetic transformation by Agrobacterium.Proc.Natl.Acad.Sci.U.S.A.102,5733
(2005).
35.A.Anand, A.Krichevsky, S.Schornack, T.Lahaye, T.Tzfira, Y.Tang,
V.Citovsky, K.S.Mysore, Arabidopsis VIRE2 INTERACTING PROTEIN2 is required for
19,1695 (2007) of Agrobacterium T-DNA integration in plants.Plant Cell
36.X.Li, Q.Yang, H.Tu, Z.Lim, S.Q.Pan, Direct visualization of
Agrobacterium-delivered VirE2 in recipient cells.Plant J.77,487 (2014)
37.B.K.Nelson, X.Cai, A.Nebenfuhr, A multicolored set of in vivo
organelle markers for co-localization studies in Arabidopsis and other
Plants.Plant J.51,1126 (2007)
38.N.Geldner, N.Anders, H.Wolters, J.Keicher, W.Komberger, P.Muller,
A.Delbarre, T.Ueda.A.Nakano, G.Jurgens, The Arabidopsis GNOM ARF-GEF mediates
Endosomal recycling, auxin transport, and auxin-dependent plant growth.Cell
112,219 (2003)
39.A.Maizel, D.von Wangenheim, F.Federici, J.Haseloff.E.H.Stelzer, High-
resolution live imaging of plant growth in near physiological bright
Conditions using light sheet fluorescence microscopy.Plant J.68,377 (2011)
40.H.T.McMahon, E.Boucrot, Molecular mechanism and physiological
Functions of clathrin-mediated endocytosis.Nat.Rev.Mol.Cell Biol.12,517
(2011).
41.S.H.Liu, M.L.Wong, C.S.Craik, F.M.Brodsky, Regulation of clathrin
Assembly and trimerization defined using recombinant triskelion hubs.Cell 83,
257(1995).
42.S.Kitakura, S.Vanneste, S.Robert, C.Lofke, T.Teichmann, H.Tanaka,
J.Friml, Clathrin mediates endocytosis and polar distribution of PIN auxin
23,1920 (2011) of transporters in Arabidopsis.Plant Cell
43.P.Dhonukshe, F.Aniento, I.Hwang, D.G.Robinson, J.Mravec, Y.D.Stierhof,
J.Friml, Clathrin-mediated constitutive endocytosis of PIN auxin efflux
Carriers in Arabidopsis.Curr.Biol.17,520 (2007)
44.S.Robert, S.N.Chary, G.Drakakaki, S.Li, Z.Yang, N.V.Raikhel, G.R.Hicks,
Endosidinl defines a compartment involved in endocytosis of the
brassinosteroid receptor BRI1 and the auxin transporters PIN2 and AUX1.Proc.
Natl.Acad.Sci.U.S.A.105,8464 (2008)
45.O.Foresti, J.Denecke, Intermediate organeiles of the plant secretory
9,1599 (2008) of pathway:identity and function.Trafffic
46.D.N.Banbury, J.D.Oakley, R.B.Sessions, G.Banting, Tyrphostin A23
inhibits internalization of the transferrin receptor by perturbing the
interaction between tyrosine motifs and the medium chain subunit of the AP-2
Adaptor complex.J.Biol.Chem.278,12022 (2003)
47.J.S.Bonifacino, L.M.Traub, Signals for sorting of transmembrane
Proteins to endosomes and lysosomes.Annu.Rev.Biochem.72,395 (2003)
48.L.M.Traub, Tickets to ride:selecting cargo for clathrin-regulated
Internalization.Nat.Rev.Mol.Cell Biol.10,583 (2009)
49.L.M.Traub, J.S.Bonifacino, Cargo recognition in clathrin-mediated
Endocytosis.Cold Spring Harb.Perspect.Biol.5, a016790 (2013)
50.L.P.Jackson.B.T.Kelly, A.J.McCoy, T.Gaffry, L.C.James, B.M.Collins,
S.Honing, P.R.Evans, D.J.Owen, A large-scale conformational change couples
membrane recruitment to cargo binding in the AP2 clathrin adaptor
141,1220 (2010) of complex.Cell
51.M.De Cleene, J.De Ley, The host range of crown gall.The Botanical
42,389 (1976) of Review
52.B.Lacroix, T.Tzfira, A.Vainstein.V.Citovsky, A case of promiscuity:
Agrobacterium ' s endless hunt for new partners.Trends Genet.22,29 (2006)
53.L.Otten.H.De Greve, J.Leemans, R.Hain, P.Hooykaas, J.Schell,
Restoration of virulence of Vir region mutants of Agrobacterium tumefaciens
strain B6S3 by coinfection with normal and mutant Agrobacterium strains.Mol
Gen Genet.195,159-163 (1984)
54.J.Aguilar, J.Zupan, T.A.Cameron, P.C.Zambryski, Agrobacterium type IV
secretion system and its substrates form helical arrays around the
Circumference of virulence-induced cells.Proc.Natl.Acad.Sci.U.S.A.107,3758
(2010).
55.L.G.Wu, E.Hamid, W.Shin, H.C.Chiang, Exocytosis and endocytosis:modes,
Functions, and coupling mechanisms.Annu.Rev.Physiol.76,301 (2014)
56.J.Mercer.M.Schelhaas, A.Helenius, Virus entry by
Endocytosis.Annu.Rev.Biochem.79,803 (2010)
57.M.Bar, A.Avni, Endosomal trafficking and signaling in plant defense
Responses.Curr.Opin.Plant Biol.22,86 (2014)
58.X.Chen, N.G.Irani, J.Friml, Clathrin-mediated endocytosis:the gateway
into plant cells.Curr.Opin.Plant Biol.14,674(2011).
59.C.Xiang, P.Han, I.Lutziger, K.Wang, D.J.Oliver, A mini binary vector
Series for plant transformation.Plant Mol.Biol.40,711-717 (1999)
60.E.E.Hood, S.B.Gelvin, L.S.Melchers, A.Hoekema, New Agrobacterium
Helper plasmids for gene transfer to plants.Transgenic Res.2,208-218 (1993)
61.V.C.Knauf, E.W.Nester, Wide host range cloning vectors:a cosmid
Clone bank of an Agrobacterium Ti plasmid.Plasmid 8,45-54 (1982)
62.P.Y.Chen, C.K.Wang, S.C.Soong, K.Y.To, Complete sequence of the binary
vector pBI121 and its application in cloning T-DNA insertion from transgenic
Plants.Mol.Breed.11,287-293 (2003)
Sequence table
<110>National University of Singapore (National University of Singapore)
<120>make the Compounds and methods for of molecular targeted specific cells position
<130> 2016-202-01
<160> 6
<170> PatentIn version 3.5
<210> 1
<211> 10
<212> PRT
<213>artificial sequence
<220>
<223>internalization signal of VirE2
<400> 1
Tyr Thr Ser Val Ala Glu Tyr Glu Arg Leu
1 5 10
<210> 2
<211> 487
<212> PRT
<213>artificial sequence
<220>
<223>N-terminal of VirE2
<400> 2
Met Asp Pro Ser Ser Asn Glu Asn Val Tyr Val Gly Arg Gly His Asn
1 5 10 15
Ile Glu Asn Asp Asp Asp Thr Asp Pro Arg Arg Trp Lys Lys Ala Asn
20 25 30
Ile Ser Ser Asn Thr Ile Ser Asp Ile Gln Met Thr Asn Gly Glu Asp
35 40 45
Val Gln Ser Gly Ser Pro Thr Arg Thr Glu Val Val Ser Pro Arg Leu
50 55 60
Asp Tyr Gly Ser Val Asp Ser Ser Ser Ser Leu Tyr Ser Gly Ser Glu
65 70 75 80
His Gly Asn Gln Ala Glu Ile Gln Lys Glu Leu Ser Val Leu Phe Ser
85 90 95
Asn Met Ser Leu Pro Gly Asn Asp Arg Arg Pro Asp Glu Tyr Ile Leu
100 105 110
Val His Gln Thr Gly Gln Asp Ala Phe Thr Gly Ile Ala Lys Gly Asn
115 120 125
Leu Asp Gln Met Pro Thr Lys Ala Glu Phe Asn Ala Cys Cys Arg Leu
130 135 140
Tyr Arg Asp Gly Ala Gly Asn Tyr Tyr Pro Pro Pro Leu Ala Phe Asp
145 150 155 160
Lys Ile Ser Val Pro Glu Gln Leu Glu Glu Lys Trp Gly Met Met Glu
165 170 175
Ala Lys Glu Arg Asn Lys Leu Arg Phe Gln Tyr Lys Leu Asp Val Trp
180 185 190
Asn His Ala His Ala Asp Met Gly Ile Thr Gly Thr Glu Ile Phe Tyr
195 200 205
Gln Thr Asp Lys Asn Ile Lys Leu Asp Arg Asn Tyr Lys Leu Arg Pro
210 215 220
Glu Asp Arg Tyr Val Gln Thr Glu Lys Tyr Gly Arg Arg Glu Ile Gln
225 230 235 240
Lys Arg Tyr Gln His Glu Leu Gln Ala Gly Ser Leu Leu Pro Asp Ile
245 250 255
Met Ile Lys Thr Pro Gln Asn Asp Ile His Phe Val Tyr Arg Phe Ala
260 265 270
Gly Asp Asn Tyr Ala Asn Lys Gln Phe Ser Glu Phe Glu His Thr Val
275 280 285
Lys Arg Arg Tyr Gly Asp Glu Thr Glu Ile Lys Leu Lys Ser Lys Ser
290 295 300
Gly Ile Met His Asp Ser Lys Tyr Leu Glu Ser Trp Glu Arg Gly Ser
305 310 315 320
Ala Asp Ile Arg Phe Ala Glu Phe Val Gly Glu Asn Arg Ala His Asn
325 330 335
Arg Gln Phe Pro Thr Ala Thr Val Asn Met Gly Gln Gln Pro Asp Gly
340 345 350
Gln Gly Gly Leu Thr Arg Asp Arg His Val Ser Val Asp Phe Leu Met
355 360 365
Gln Ser Ala Pro Asn Ser Pro Trp Ala Gln Ala Leu Lys Lys Gly Glu
370 375 380
Leu Trp Asp Arg Val Gln Leu Leu Ala Arg Asp Gly Asn Arg Tyr Leu
385 390 395 400
Ser Pro Pro Arg Leu Glu Tyr Ser Asp Pro Ala His Phe Thr Glu Leu
405 410 415
Met Asn Arg Val Gly Leu Pro Ala Ser Met Gly Arg Gln Ser His Ala
420 425 430
Ala Ser Ile Lys Phe Glu Lys Phe Asp Ala Gln Ala Ala Val Ile Val
435 440 445
Leu Asn Gly Pro Glu Leu Arg Asp Ile His Asp Leu Ser Pro Glu Lys
450 455 460
Leu Gln Asn Leu Ser Thr Lys Asp Val Ile Val Ala Asp Arg Asn Glu
465 470 475 480
Asn Gly Gln Arg Thr Gly Thr
485
<210> 3
<211> 52
<212> PRT
<213>artificial sequence
<220>
<223>C-terminal of VirE2
<400> 3
Gln Leu Arg Leu Pro Pro Asp Ala Ala Gly Val Leu Gly Glu Ala Thr
1 5 10 15
Asp Lys Tyr Ser Arg Asp Phe Val Arg Pro Glu Pro Ala Ser Arg Pro
20 25 30
Ile Ser Asp Ser Arg Arg Ile Tyr Glu Ser Arg Pro Arg Ser Gln Ser
35 40 45
Val Asn Ser Phe
50
<210> 4
<211> 549
<212> PRT
<213>Agrobacterium tumefaciems (Agrobacterium tumefaciens)
<400> 4
Met Asp Pro Ser Ser Asn Glu Asn Val Tyr Val Gly Arg Gly His Asn
1 5 10 15
Ile Glu Asn Asp Asp Asp Thr Asp Pro Arg Arg Trp Lys Lys Ala Asn
20 25 30
Ile Ser Ser Asn Thr Ile Ser Asp Ile Gln Met Thr Asn Gly Glu Asp
35 40 45
Val Gln Ser Gly Ser Pro Thr Arg Thr Glu Val Val Ser Pro Arg Leu
50 55 60
Asp Tyr Gly Ser Val Asp Ser Ser Ser Ser Leu Tyr Ser Gly Ser Glu
65 70 75 80
His Gly Asn Gln Ala Glu Ile Gln Lys Glu Leu Ser Val Leu Phe Ser
85 90 95
Asn Met Ser Leu Pro Gly Asn Asp Arg Arg Pro Asp Glu Tyr Ile Leu
100 105 110
Val His Gln Thr Gly Gln Asp Ala Phe Thr Gly Ile Ala Lys Gly Asn
115 120 125
Leu Asp Gln Met Pro Thr Lys Ala Glu Phe Asn Ala Cys Cys Arg Leu
130 135 140
Tyr Arg Asp Gly Ala Gly Asn Tyr Tyr Pro Pro Pro Leu Ala Phe Asp
145 150 155 160
Lys Ile Ser Val Pro Glu Gln Leu Glu Glu Lys Trp Gly Met Met Glu
165 170 175
Ala Lys Glu Arg Asn Lys Leu Arg Phe Gln Tyr Lys Leu Asp Val Trp
180 185 190
Asn His Ala His Ala Asp Met Gly Ile Thr Gly Thr Glu Ile Phe Tyr
195 200 205
Gln Thr Asp Lys Asn Ile Lys Leu Asp Arg Asn Tyr Lys Leu Arg Pro
210 215 220
Glu Asp Arg Tyr Val Gln Thr Glu Lys Tyr Gly Arg Arg Glu Ile Gln
225 230 235 240
Lys Arg Tyr Gln His Glu Leu Gln Ala Gly Ser Leu Leu Pro Asp Ile
245 250 255
Met Ile Lys Thr Pro Gln Asn Asp Ile His Phe Val Tyr Arg Phe Ala
260 265 270
Gly Asp Asn Tyr Ala Asn Lys Gln Phe Ser Glu Phe Glu His Thr Val
275 280 285
Lys Arg Arg Tyr Gly Asp Glu Thr Glu Ile Lys Leu Lys Ser Lys Ser
290 295 300
Gly Ile Met His Asp Ser Lys Tyr Leu Glu Ser Trp Glu Arg Gly Ser
305 310 315 320
Ala Asp Ile Arg Phe Ala Glu Phe Val Gly Glu Asn Arg Ala His Asn
325 330 335
Arg Gln Phe Pro Thr Ala Thr Val Asn Met Gly Gln Gln Pro Asp Gly
340 345 350
Gln Gly Gly Leu Thr Arg Asp Arg His Val Ser Val Asp Phe Leu Met
355 360 365
Gln Ser Ala Pro Asn Ser Pro Trp Ala Gln Ala Leu Lys Lys Gly Glu
370 375 380
Leu Trp Asp Arg Val Gln Leu Leu Ala Arg Asp Gly Asn Arg Tyr Leu
385 390 395 400
Ser Pro Pro Arg Leu Glu Tyr Ser Asp Pro Ala His Phe Thr Glu Leu
405 410 415
Met Asn Arg Val Gly Leu Pro Ala Ser Met Gly Arg Gln Ser His Ala
420 425 430
Ala Ser Ile Lys Phe Glu Lys Phe Asp Ala Gln Ala Ala Val Ile Val
435 440 445
Leu Asn Gly Pro Glu Leu Arg Asp Ile His Asp Leu Ser Pro Glu Lys
450 455 460
Leu Gln Asn Leu Ser Thr Lys Asp Val Ile Val Ala Asp Arg Asn Glu
465 470 475 480
Asn Gly Gln Arg Thr Gly Thr Tyr Thr Ser Val Ala Glu Tyr Glu Arg
485 490 495
Leu Gln Leu Arg Leu Pro Pro Asp Ala Ala Gly Val Leu Gly Glu Ala
500 505 510
Thr Asp Lys Tyr Ser Arg Asp Phe Val Arg Pro Glu Pro Ala Ser Arg
515 520 525
Pro Ile Ser Asp Ser Arg Arg Ile Tyr Glu Ser Arg Pro Arg Ser Gln
530 535 540
Ser Val Asn Ser Phe
545
<210> 5
<211> 16
<212> PRT
<213>artificial sequence
<220>
<223> GFP11
<400> 5
Arg Asp His Met Val Leu His Glu Tyr Val Asn Ala Ala Gly Ile Thr
1 5 10 15
<210> 6
<211> 215
<212> PRT
<213>artificial sequence
<220>
<223> GFP1-10
<400> 6
Met Val Ser Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu
1 5 10 15
Val Glu Leu Asp Gly Asp Val Asn Gly His Lys Phe Ser Val Arg Gly
20 25 30
Glu Gly Glu Gly Asp Ala Thr Ile Gly Lys Leu Thr Leu Lys Phe Ile
35 40 45
Cys Thr Thr Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr
50 55 60
Leu Thr Tyr Gly Val Gln Cys Phe Ser Arg Tyr Pro Asp His Met Lys
65 70 75 80
Arg His Asp Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu
85 90 95
Arg Thr Ile Ser Phe Lys Asp Asp Gly Lys Tyr Lys Thr Arg Ala Val
100 105 110
Val Lys Phe Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly
115 120 125
Thr Asp Phe Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr
130 135 140
Asn Phe Asn Ser His Asn Val Tyr Ile Thr Ala Asn Lys Gln Lys Asn
145 150 155 160
Gly Ile Lys Ala Asn Phe Thr Val Arg His Asn Val Glu Asp Gly Ser
165 170 175
Val Gln Leu Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly
180 185 190
Pro Val Leu Leu Pro Asp Asn His Tyr Leu Ser Thr Gln Thr Val Leu
195 200 205
Ser Lys Asp Pro Asn Glu Lys
210 215
Claims (23)
1. peptide, the peptide includes or is made up of: the amino acid sequence or (ii) of (i) SEQ ID NO:1 is in its whole length
The upper amino acid sequence with amino acid sequence at least 80% sequence identity of SEQ ID NO:1.
2. peptide according to claim 1, wherein the length of the peptide is 10 to 200 amino acid.
3. conjugate, the conjugate includes peptide according to claim 1 or 2, wherein the peptide further includes at least one
Funtion part.
4. conjugate according to claim 3, wherein the N-terminal of at least one described funtion part and the peptide is conjugated.
5. conjugate according to claim 3, wherein the C-terminal of at least one described funtion part and the peptide is conjugated.
6. conjugate according to claim 4 is not, it is specified that at least one described funtion part includes described in SEQ ID NO:2
Amino acid sequence or its C-terminal segment.
7. conjugate according to claim 5 is not, it is specified that at least one described funtion part includes described in SEQ ID NO:3
Amino acid sequence or its N-terminal segment.
8. the conjugate according to any one of claim 3 to 7, wherein the funtion part be pharmaceutically or biology
On reactive compound.
9. the conjugate according to any one of claim 3 to 8, wherein the funtion part further includes or green fluorescence
Albumen (GFP) or its segment.
10. the conjugate according to any one of claim 3 to 9, wherein the conjugate further includes that at least one is used for
Translocate to the part in cell.
11. conjugate according to claim 10, wherein the part for translocating in cell is the end C of VirE2
Terminal sequence.
12. conjugate according to claim 10, wherein the part for translocating in cell is cell-penetrating peptides
Or reagent.
13. a kind of carrier, the carrier includes a nucleotide sequence, it is described it is nucleotide sequence coded according to claim 1 or 2 institutes
The peptide stated.
14. a kind of host cell, the host cell includes carrier according to claim 13.
15. a kind of for visualizing the biological imaging systems of internalization process comprising:
(a) conjugate according to any one of claim 3 to 12 is conjugated with the first GFP segment;With
(b) cell expresses the 2nd GFP segment,
Wherein the first GFP segment and the 2nd GFP segment can assemble to form functional GFP.
16. biological imaging systems according to claim 15, wherein
(a) conjugate described in (a) is conjugated with according to the peptide of SEQ ID NO:5;And/or
(b) cell expresses the peptide according to SEQ ID NO:6.
17. biological imaging systems according to claim 15 or 16, wherein the cell is selected from by plant cell, yeast
The group that cell, fungi, algae or the mammalian cell of culture are constituted.
18. biological imaging systems according to claim 17, wherein the cell is plant cell.
19. biological imaging systems described in any one of 5 to 18 according to claim 1, wherein the cell expresses clathrin
Relevant adapter AP2 complex (AP2M).
20. a kind of method for visualizing internalization process comprising:
According to claim 1, biological imaging systems described in any one of 5 to 19 are provided;With
Conjugate described in claim 16 (a) is set to be in contact with cell described in claim 16 (b).
21. a kind of make drug internalization to intracellular method comprising:
The conjugate according to any one of claim 8 to 12 and cell are provided;With
The conjugate is set to be in contact with the cell.
22. the conjugate according to any one of claim 8 to 12 is used as drug.
23. purposes of the conjugate according to any one of claim 8 to 12 as investigational agent.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG10201608928QA SG10201608928QA (en) | 2016-10-24 | 2016-10-24 | Compounds and methods to target a molecule to a specific cellular location |
SG10201608928Q | 2016-10-24 | ||
PCT/SG2017/050533 WO2018080396A2 (en) | 2016-10-24 | 2017-10-24 | Compounds and methods to target a molecule to a specific cellular location |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110036021A true CN110036021A (en) | 2019-07-19 |
CN110036021B CN110036021B (en) | 2023-04-11 |
Family
ID=62025316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201780065902.5A Active CN110036021B (en) | 2016-10-24 | 2017-10-24 | Compounds and methods for targeting molecules to specific cellular locations |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN110036021B (en) |
SG (1) | SG10201608928QA (en) |
WO (1) | WO2018080396A2 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10254167A1 (en) * | 2002-11-20 | 2004-06-09 | Icon Genetics Ag | Process for the control of cellular processes in plants |
US8053638B2 (en) * | 2006-08-07 | 2011-11-08 | The Samuel Roberts Noble Foundation | Method for agrobacterium-mediated transformation of plants |
-
2016
- 2016-10-24 SG SG10201608928QA patent/SG10201608928QA/en unknown
-
2017
- 2017-10-24 CN CN201780065902.5A patent/CN110036021B/en active Active
- 2017-10-24 WO PCT/SG2017/050533 patent/WO2018080396A2/en active Application Filing
Non-Patent Citations (3)
Title |
---|
MARK SIMONE ET AL.: "The carboxy-terminus of VirE2 from Agrobacterium tumefaciens is required for its transport to host cells by the virB-encoded type IV transport system", 《MOLECULAR MICROBIOLOGY》 * |
XIAOYANG LI ET AL.: "Direct visualization of Agrobacterium-delivered VirE2 in recipient cells", 《THE PLANT JOURNAL》 * |
无: "Type IV secretion system single-stranded DNA-binding protein VirE2 [Agrobacterium tumefaciens],GENBANK ACCESSION NO.: WP_012478091", 《GENBANK》 * |
Also Published As
Publication number | Publication date |
---|---|
WO2018080396A2 (en) | 2018-05-03 |
WO2018080396A3 (en) | 2018-09-27 |
SG10201608928QA (en) | 2018-05-30 |
CN110036021B (en) | 2023-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230287440A1 (en) | Recombinant vector for producing antigen for diagnosis of african swine fever and use therof | |
KR20110009197A (en) | Bacterial toxin vaccine | |
CN112143746A (en) | Gene GmAP5 for improving disease resistance of plants and application thereof | |
Li et al. | Agrobacterium delivers anchorage protein VirE3 for companion VirE2 to aggregate at host entry sites for T-DNA protection | |
AU2010360293A1 (en) | Molecular interaction between Xa10 and AvrXa10 | |
CN109929019A (en) | A kind of and plant salt tolerance alkali GAP-associated protein GAP GsERF7 and its encoding gene and application | |
CN110818784B (en) | Application of rice gene OsATL15 in regulation of absorption and transportation of pesticides | |
CN107936099B (en) | LHAP1 protein and application of encoding gene thereof in regulation and control of plant photosynthesis | |
US20130219559A1 (en) | Method for hydrophobin production in plants and methods to produce hydrophobin multimers in plants and microbes | |
CN110036021A (en) | Make the Compounds and methods for of molecular targeted specific cells position | |
CN110218247A (en) | Two kinds of interactions between protein collaborations of PwRBP1 and PwNAC1 improve plant stress tolerance and its application | |
US10526611B2 (en) | Gene targeting using mutant Agrobacterium strains | |
CN110628807B (en) | Salicornia europaea SePSS protein and coding gene and application thereof | |
WO2015133652A1 (en) | Plant transformation method | |
CN102485750B (en) | Plant anti-oxidation associated protein SsOEP8, coding gene thereof, and application thereof | |
CN112481232A (en) | Bacterial protein lysine deacetylation modification enzyme and application thereof | |
WO2015077620A1 (en) | Compositions and methods for galls fl and galls ct mediated transformation of plants | |
CN108192919A (en) | A kind of method for cultivating drought resisting transgene cotton | |
Drehkopf et al. | Functional characterization of VirB/VirD4 and Icm/Dot type IV secretion systems from the plant-pathogenic bacterium Xanthomonas euvesicatoria | |
WO2009145180A1 (en) | Novel selection marker gene and use thereof | |
Zakharchenko et al. | Use of the gene of antimicrobial peptide cecropin P1 for producing marker-free transgenic plants | |
Liu et al. | Myosin VIII and XI isoforms interact with Agrobacterium VirE2 protein and help direct transport from the plasma membrane to the perinuclear region during plant transformation | |
CN110462045B (en) | Marker, method and kit for observing influence of compound or drug on cells in real time and application of marker | |
MacMillan | Plant organelle targeting cell penetrating peptides | |
CN102070705A (en) | Plant stress tolerance-relevant protein TaFbox2, coding gene and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |